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X-linked cone-rod dystrophy is a retinal disease 
characterized by progressive loss of cone and 
rod photoreceptor functions. Affected males 
show reduced visual acuity, photophobia, 
myopia, color vision defects, central scotomas, 
and variable fundus changes. The disease is 
genetically heterogeneous and two disease 
loci, CORDX1 and CORDX2, were known 
prior to the present thesis work. CORDX1, 
located on chromosome Xp21.1-11.4, is caused 
by mutations in the RPGR gene, which was 
originally identifi ed as the causative gene for 
RP3 type retinitis pigmentosa. CORDX2 is 
located on Xq27-28 but the causative gene is 
still unknown.
Åland Island eye disease (AIED), also 
known as Forsius-Eriksson syndrome, or 
Forsius-Eriksson type ocular albinism, is 
a retinal disease characterized by fundus 
hypopigmentation, decreased visual acuity, 
nystagmus, astigmatism, red color vision 
defect, myopia, and defective night vision. AIED 
shares similarities with another retinal disease, 
congenital stationary night blindness (CSNB2). 
Mutations in the L-type calcium channel α1F-
subunit gene, CACNA1F, are known to cause 
CSNB2, as well as AIED-like disease. The 
disease locus of the original AIED family maps 
to the same genetic interval as the CACNA1F 
gene, but fi rst sequencing attempts in the 
patients of the original AIED family have failed 
to reveal any CACNA1F mutations.
The aims of this study were to map the disease 
gene in a large Finnish family with X-linked 
cone-rod dystrophy, to identify the disease 
genes behind the cone-rod dystrophy and AIED 
phenotypes, and to determine the functional 
consequences of the mutations identifi ed. With 
the help of linkage and haplotype analyses, we 
could localize the disease gene of the Finnish 
cone-rod dystrophy family to the Xp11.4-
Xq13.1 region, and thus establish a new genetic 
X-linked cone-rod dystrophy locus, CORDX3. 
Mutation analyses of candidate genes 
revealed a novel CACNA1F gene mutation, 
IVS28-1 GCGTC>TGG, in CORDX3 patients. 
Surprisingly, a 425 bp CACNA1F gene deletion, 
comprising exon 30 and parts of the adjacent 
intronic regions, was identifi ed in AIED patients. 
An additional Finnish patient with a CSNB2-like 
phenotype was later included in the mutation 
analysis, which led to the identifi cation of a third 
CACNA1F gene mutation, IVS16+2T>C. All 
three novel mutations altered splice sites of the 
CACNA1F gene, and resulted in defective pre-
mRNA splicing. Several aberrant splice variants 
were observed predicting different sized 
deletions or premature termination codons 
(PTCs) to the calcium channel α1F-subunit 
protein. Altered or absent channel function 
is thus the probable disease mechanism 
resulting from these mutations. The analyses 
of CACNA1F mRNA also revealed novel 
alternative wt splice variants. These variants 
predicted PTCs or deletions in the channel 
protein, suggesting that alternative splicing 
has an important role in enhancing channel 
diversity and regulating the overall expression 
level of the channel.
Several researchers have studied the functional 
consequences of CACNA1F mutations by over-
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expressing mutant channels in kidney cells or 
Xenopus laevis oocytes. In this study, however, 
overexpression of even the wt channel in 
kidney cells resulted in misfolding of the 
channel protein and consequent formation of 
protein aggregates. Thus, other approaches 
are needed to reveal the actual functional 
consequences of the observed CACNA1F 
mutations.
The phenotypic spectrum associated 
with CACNA1F mutations is wide. Distinct 
mutations may lead to several different retinal 
phenotypes, including 1) CSNB2, 2) CSNB2 
with atypical retinal atrophy and visual fi eld 
defects, 3) atrophy of the retina and the optic 
discs, 4) severe CSNB2-like phenotype with 
intellectual disability and symptoms in female 
carriers, and 5) AIED-like phenotype. In 
this study, mutations were also identifi ed in 
patients with CORDX3 and AIED. All these eye 
disorders have a few symptoms in common, 
suggesting that thorough clinical examination, 
together with genetic testing, is necessary to 
reach a correct diagnosis.
Abstract
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REVIEW OF THE LITERATURE
1 Disease gene identifi cation
1.1 The Human Genome Project
Detailed information of the human genome 
is crucial for our understanding of human 
biology and the great number of disorders 
that can affect us. In order to understand the 
structure and function of the human genome, 
an international research program, the Human 
Genome Project (HGP, www.genomics.energy.
gov), was launched in 1990 by the National 
Institutes of Health and the U.S. Department of 
Energy. The main goals of the project were to 
determine the complete DNA sequence of the 
human genome, identify all the genes encoded 
by human DNA, and store this information in 
public databases available to researchers 
around the world. 
The estimated size of the human genome is 
3.2 gigabases (Gb), of which about 2.95 Gb is 
euchromatic, i.e. gene-rich regions, as opposed 
to heterochromatic regions (Baltimore 2001). 
The fi rst steps to reveal the DNA sequence of 
the euchromatic portion of the genome were 
taken in the mid 1990's, when comprehensive 
genetic and physical maps of the human 
genome were constructed, providing key tools 
for the identifi cation of disease genes (Dib et 
al. 1996; Gyapay et al. 1994; Hudson et al. 
1995). The fi rst entire human chromosome 
sequence was published in December 1999 
for the smallest chromosome, chromosome 
22 (Dunham et al. 1999). In February 2001, 
the fi rst draft sequence, covering 90% of the 
euchromatic regions of the human genome, 
was reported at the same time by the HGP 
(Lander et al. 2001) and a private company, 
Celera Genomics (Venter et al. 2001). In April 
2003, special issues of Nature and Science 
presented the completion of the HGP, which 
had accomplished the sequencing of nearly 
the entire euchromatic portion of the human 
genome with almost 100% accuracy. The 
complete sequences for the remaining 
chromosomes were published subsequently, 
and fi nally, in May 2006, the entire euchromatic 
sequence of the last unsequenced chromo-
some, chromosome 1, was published (Gregory 
et al. 2006).  Sequencing of the entire genome 
from a number of individuals revealed 3.7 
million single nucleotide polymorphisms 
(SNPs), which serve as valuable tools in the 
identifi cation of disease genes. 
The most surprising fi nding of the HGP was 
that the number of human genes appeared to 
be signifi cantly lower than previous estimates, 
which ranged from approximately 35,000 
to as many as 140,000 (Aparicio 2000). 
According to the latest estimates, the human 
genome contains 20,000-25,000 protein-
coding genes, which cover less than 2% of 
the euchromatic DNA (International Human 
Genome Sequencing Consortium 2004). At 
the moment, the Ensemble databank lists 
21,541 protein-coding genes and 4421 RNA 
genes (www.ensembl.org). The rest of the 
DNA consists to a great extent of various types 
of repeat sequences, including transposon-
derived repeats, pseudogenes, simple 
sequence repeats, segmental duplications, and 
blocks of tandemly repeated sequences such 
as centromeres, telomeres, and the short arms 
of acrocentric chromosomes, which together 
account for at least 50% of the human genome 
(Lander et al. 2001). Other regions include 
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regulatory regions as well as regions of as yet 
unknown features (Birney et al. 2001).
1.2 The ENCODE project
The HGP provided accurate DNA sequences 
for each of our 24 chromosomes. Knowledge 
about protein-coding regions of the human 
genome, however, remains incomplete. The 
understanding of both non-protein-coding 
transcripts and functional, noncoding genomic 
elements remains even poorer (Birney et 
al. 2007). The ENCODE (ENCyclopedia Of 
DNA Elements, www.genome.gov/ENCODE) 
project was launched in September 2003 
by the National Human Genome Research 
Institute in order to identify functional elements 
in the human genome, including protein-
coding genes, non-protein-coding genes, 
transcriptional regulatory elements, sequences 
that mediate chromosome structure and 
dynamics, and as yet undefi ned functional 
sequences (ENCODE Project Consortium 
2004). ENCODE is being conducted in 
three phases: a pilot phase, a technology 
development phase, and a production phase. 
The pilot phase, in which the ENCODE 
Consortium is evaluating strategies for 
identifying various types of genomic elements, 
is focused on a selected 30 megabases (Mb) 
that encompasses  1% of the human genome. 
The goal of the pilot phase is to test a set of 
procedures that can be applied to characterize 
the remaining 99% of the human genome.
Results from the pilot phase were published 
in June 2007 (Birney et al. 2007). One of the 
major fi ndings of this project was that protein-
coding genes seem to be transcriptionally 
much more complex than previously thought. 
Instead of the traditional view that many genes 
have several alternatively spliced transcripts 
that code for alternative proteins, the ENCODE 
data suggests that, in addition, genes may 
produce other coding or regulatory transcripts 
that include sequences from both strands or 
even from neighboring genes. These fi ndings 
prompted researchers to update the defi nition 
of the gene from “the DNA segment that 
contributes to phenotype/function” to “union 
of genomic sequences encoding a coherent 
set of potentially overlapping functional 
products” (Gerstein et al. 2007). Also, large 
sections of DNA not annotated as known 
genes seem to be transcribed into RNA (Birney 
et al. 2007). All these noncoding RNA products 
do not necessarily have a function themselves, 
but transcription of a certain region may be 
important for chromatin accessibility during 
DNA replication or binding of transcription 
factors (Gerstein et al. 2007). 
1.3 Positional cloning of disease genes
The majority of the disease genes discovered 
in the early days of molecular genetics, during 
the 1980’s, were identifi ed by the functional 
cloning approach (Collins 1992). In this strategy, 
knowledge about the chromosomal location of 
the disease gene is not needed, and a gene is 
cloned solely based on the exact information 
about the basic biochemical defect. As the 
defective protein is known, a cDNA sequence 
of the corresponding gene can be produced 
following protein sequencing or by purifying the 
corresponding mRNA by immunoprecipitation, 
and then trapping the appropriate clone from 
a cDNA library. This strategy was successfully 
used for example in the identifi cation of the 
disease gene for phenylketonuria (Robson 
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et al. 1982). Because detailed information of 
the biochemical defect is rarely available, new 
strategies were developed for more effi cient 
disease gene discovery.
Positional cloning is a method of gene 
discovery where a disease gene is isolated 
based on its chromosomal location without 
any prior information on the gene function 
(Collins 1992; Collins 1995). In some cases 
the presence of chromosomal aberrations may 
help to locate the disease gene (Ballabio 1993). 
The mode of inheritance may also defi ne the 
candidate region to a certain chromosome, 
as in the case of X-linked diseases. The 
Duchenne muscular dystrophy (DMD) gene 
was one of the fi rst disease genes isolated 
by positional cloning method, taking the 
advantage of both the X-linked inheritance and 
chromosomal deletions observed in patients 
(Monaco et al. 1986). In most cases, however, 
the location of the gene of interest is defi ned by 
linkage analysis utilizing families with affected 
individuals. In traditional positional cloning, the 
steps following linkage analysis were usually 
very laborious, including construction of a 
continuum of overlapping genomic clones for 
the candidate region, isolation of DNA from 
the clones, identifi cation of transcripts, and 
cloning the cDNAs. Nowadays, the availability 
of DNA sequence and tools for sequence 
analysis in public databases has revolutionized 
traditional positional cloning, allowing the use 
of the positional candidate gene method. Once 
the region of interest has been identifi ed by 
linkage analysis, all the genes mapping to this 
region may serve as potential candidate genes 
(Collins 1995). Information on gene function, 
expression profi les, or homologous genes 
in other organisms may point to the most 
attractive candidate genes, which then can be 
screened for disease-associated mutations. 
Several methods for mutation detection 
exist, showing variability in both sensitivity 
and expense. Following rapid development 
of automated DNA sequencing techniques, 
direct sequencing is often the most favorable 
choice for mutation detection, provided that 
the number of samples is reasonable. The 
positional candidate gene strategy has been 
successful in identifying a number of disease 
genes, including the disease genes identifi ed 
in this thesis.
1.4 Linkage and linkage disequilibrium   
 analyses
Linkage analysis is a powerful tool in defi ning 
the chromosomal locations of disease genes, 
and it is often the fi rst step in disease gene 
identifi cation. Linkage analysis is based on the 
observation that loci that reside physically close 
to each other on the same chromosome only 
rarely separate from each other due to crossing 
over (i.e. a recombination event) during meiosis 
(Lathrop et al. 1984; Pulst 1999). When two 
loci are located on distinct chromosomes 
or on the same chromosome but far away 
from each other, their alleles will be inherited 
independently, according to Mendel’s laws. On 
the other hand, when two loci are situated close 
enough on the same chromosome, their alleles 
will be inherited together from one generation 
to the next more often than would be expected 
by chance, and these loci are said to be linked 
(de la Chapelle et al. 1994). 
The frequency of observed recombinations (the 
recombination fraction, θ) is used to calculate 
the genetic distance between two loci (Pericak-
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Vance 1998). The unit for genetic distance is 
the centiMorgan (cM), which corresponds to a 
recombination fraction of 0.01 (1%). When the 
recombination fraction exceeds 0.05-0.1 (5-
10%), it does not correlate directly with cMs, 
because double crossing-overs are likely to 
occur. Several map functions are available to 
calculate genetic distances corresponding to 
certain recombination fractions (Haldane 1919; 
Kosambi 1944). If the recombination fraction 
exceeds 0.5 (50%), two loci are inherited 
independently, as for those located on distinct 
chromosomes, and linkage is absent. 
The total genetic length of the human genome is 
~3700 cM, and, on average, 1 cM corresponds 
to a physical distance of 1 Mb (Pulst 1999). 
Because recombinations occur more often 
during female than male meioses, the genetic 
map in females is longer than in males (Dib et al. 
1996). Recombinations are also most frequent in 
telomeric and subtelomeric regions. According 
to recent studies, recombination events 
occur nonrandomly at specifi c 1-2 kilobase 
(kb) recombination “hot spots”, whereas the 
surrounding regions are “cold” (Kauppi et 
al. 2004). The nature of recombination hot 
spots is not fully understood, and hot spots 
located in different genomic regions share 
no obvious sequence similarities with each 
other. Chromatin structure seems, however, 
to play a partial role in the determination of 
recombination sites. 
The statistical signifi cance of linkage is 
measured by the logarithm of odds (LOD) 
score (Morton 1955). The lod score (Z) is 
a 10th base logarithm of the likelihood that 
two loci are linked at a certain recombination 
fraction divided by the likelihood that the two 
loci are unlinked (θ=0.5). At the maximum lod 
score value, the corresponding recombination 
fraction gives the most likely genetic distance 
between the loci. A lod score of 3 or higher 
(odds ratio 1000:1 favoring linkage) is generally 
accepted as evidence of linkage, whereas at 
lod scores of -2 or less linkage is excluded.
In genetically homogenous populations, 
the candidate region determined by linkage 
analysis (typically several Mbs), is often 
narrowed down by linkage disequilibrium 
analysis (Terwilliger 1995; Xiong and Guo 
1997). Linkage disequilibrium refers to the 
situation that specifi c alleles at two loci 
occur together more often at the population 
level than would be expected from the allele 
frequencies (Pulst 1999). The power of linkage 
disequilibrium comes from the utilization 
of historical recombinations from past 
generations (Jorde 1995). When a mutation 
is fi rst introduced into a population, it appears 
in a single chromosome containing a certain 
series of marker alleles, called a haplotype. 
Throughout the generations, recombinations 
occur between the disease gene and the 
marker loci, and the common haplotype 
fl anking the mutation becomes smaller. The 
size of the common haplotype associated with 
the disease mutation depends on two factors: 
recombination frequency and the number of 
generations since the mutation was introduced 
to the population. Linkage disequilibrium can 
be expected only if the disease mutation in a 
population is of single-origin (a new mutation 
or immigration of the mutation carrier), a so 
called founder mutation (de la Chapelle and 
Wright 1998). Other important determinants 
of a population that can be studied by linkage 
disequilibrium mapping include a relatively small 
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number of founder individuals, the expansion 
of the population by growth rather than by 
immigration, and large enough population size 
to provide affected individuals to study. The 
Finnish population is a well-known example 
of a population which fulfi lls these criteria, and 
linkage disequilibrium has been successfully 
used in identifying the genetic background 
of many diseases belonging to the Finnish 
disease heritage, such as diastrophic dysplasia 
(Hästbacka et al. 1994), infantile neuronal ceroid 
lipofuscinosis (INCL) (Järvelä 1991; Vesa et al. 
1995), and progressive myoclonus epilepsy 
(EPM1) (Pennacchio et al. 1996; Virtaneva et 
al. 1996).  
1.5  Genetic markers
Linkage analysis is based on the segregation 
of alleles at polymorphic loci (genetic 
markers) in families with affected individuals. 
Polymorphisms are defi ned as DNA sequence 
differences that are present in over 1% of a 
given population. Polymorphisms occur most 
frequently in noncoding regions, but when 
present in a coding region they do not usually 
change the amino acid, or alternatively, the 
amino acid change is silent and the protein 
function is unaffected (Jalanko et al. 1996). The 
most useful polymorphisms in linkage studies 
are abundant, easy to genotype, and have high 
degree of heterozygosity. 
The fi rst polymorphic markers utilized in linkage 
analyses were restriction fragment length 
polymorphisms (RFLPs). RFLPs are caused 
by a single nucleotide change in the specifi c 
recognition site of restriction endonucleases, 
or by deletions and insertions in the restriction 
fragments (Botstein et al. 1980). The use-
fulness of RFLPs is limited because of the 
laborious methodology, and relatively low 
information content. With the advent of the 
polymerase chain reaction (PCR) (Mullis et al. 
1986), RFLPs were soon replaced by more 
informative minisatellite (Jeffreys et al. 1985) 
and microsatellite markers (Weber and May 
1989). The disadvantage of minisatellites is that 
they are nonrandomly dispersed in the human 
genome, showing preferential localization to 
the ends of chromosomes (Royle et al. 1988). 
Microsatellites (di-, tri-, and tetranucleotide 
repeats), on the other hand, are dispersed 
relatively equally throughout the genome (Li 
et al. 2002). Furthermore, they have high allelic 
diversity and therefore high heterozygosity. 
Recent interest has, however, turned back 
to single nucleotide polymorphisms (SNPs). 
Although SNPs are less informative than 
microsatellite markers, their abundance and the 
recent advances in automation of genotyping 
by novel “chip”- or microarray-based methods 
(such as those developed by Affymetrix, 
Illumina, and Sequenom) have made them 
a powerful tool for gene mapping studies. 
Other benefi ts of SNPs include lower de novo 
mutation rates than those of microsatellites, 
and occurrence in both noncoding and coding 
regions (Gray et al. 2000).
2  Physiology of vision
Vision has an important role in the 
understanding of the world around us. Visual 
perception begins in the back of the eye, where 
a thin layer of neural cells, called the retina, 
gathers and processes information about light, 
colors, shapes, and movements of the outside 
world, to be transferred to and interpreted by 
the brain. 
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2.1  Retinal development
The vertebrate eye is a complicated structure, 
comprising a number of different tissue types. 
During vertebrate embryogenesis the eye 
develops as a consequence of interactions 
between the surface ectoderm and embryonic 
forebrain (Wong 2006). The retina forms as a 
forebrain evagination, the optic vesicle, folds 
inward to form an optic cup. The outer wall 
of the optic cup becomes the retinal pigment 
epithelium (RPE), whereas cells in the inner 
wall differentiate into the neural retina. The 
optic stalk, connecting the optic vesicle to the 
developing brain, eventually becomes the optic 
nerve. 
In humans, eyes start to develop three 
weeks after fertilization (Mann 1964). By 
embryonal week 30, cell proliferation is 
complete throughout the retina (Provis et 
al. 1985a). Cell differentiation occurs in two 
phases: ganglion cells, horizontal cells, and 
cone photoreceptors are generated in the 
early phase, whereas amacrine cells, bipolar 
cells, rod photoreceptors, and Müller glia 
cells differentiate in the later phase (Rapaport 
2006). Retinal neurogenesis occurs in concert 
with programmed cell death: approximately 
70% of the ganglion cells generated during 
development are lost in fetal life (Provis et al. 
1985b). The rate of developmental cell death 
among other retinal cells is less clear. Retinal 
differentiation is not fully completed during 
fetal life, and maturation continues even several 
months after birth (Yuodelis and Hendrickson 
1986).
2.2 Retinal structure
The neural retina is arranged in a typical 
layered structure found in all vertebrates 
(Figure 1) (Dowling 1987). Photoreceptors 
constitute the outermost layer, hence, light 
must travel through all the other retinal layers 
to reach the light-sensitive cells. The two 
major types of photoreceptors are rods and 
cones. Rod photoreceptors are extremely 
sensitive to light, and thereby mediate vision 
in dim light, whereas cones are specialized to 
operate in bright light, and are responsible for 
high resolution color vision. The proportions of 
photoreceptors vary widely between different 
retinal regions, and also between species. 
The Chicken (Gallus domesticus) retina, for 
example, is cone-dominated (Trevino et al. 
2005), whereas the frog (Xenopus laevis) has 
roughly equal numbers of rods and cones 
(Chang and Harris 1998). In human retina, rods 
are the predominant receptor type (Curcio et 
al. 1990). Cone density is highest in the foveal 
region, located in the center of the macula 
lutea, and falls steeply outside the fovea. The 
foveola in the center of the fovea, responsible 
for the highest visual acuity, is a rod-free zone 
containing only cones. The rod cells are the 
predominant receptor type outside the fovea 
with highest density in the ring-like area at a 
distance of about 3-5 mm from the foveola 
(Jonas et al. 1992). The optic disc, where 
ganglion cell axons exit the eye to form the optic 
nerve, does not contain any photoreceptors, 
and is therefore also referred to as “the blind 
spot” (Awater et al. 2005).
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Figure 1. Retinal anatomy and the main cell types. All vertebrate retinas are composed of three 
layers of nerve cell bodies (ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell 
layer), and two layers of synapses (OPL, outer plexiform layer; IPL, inner plexiform layer). The 
photoreceptors, rods and cones, convert the light stimulus into electrical and chemical signals, 
and transfer the information to bipolar cells (BC). Bipolar cells are in contact with ganglion cells 
(GC) whose axons form the optic nerve connecting the retina to the brain. Lateral information fl ow 
is mediated by horizontal cells (HC), which operate at the OPL, and amacrine cells (AC), which 
function at the IPL. Müller cells (MC) extend through the entire retina providing functional and 
structural support. In reality, the retina is a much more complex structure, and many of the main cell 
types contain several subtypes each with specifi c functions (Masland 2001). The retinal pigment 
epithelium (RPE) just behind the neural retina provides metabolic support to the photoreceptors. 
Image adapted from University of Melbourne, Department of Anatomy and Cell biology web pages 
(www.anatomy.unimelb.edu.au/researchlabs/rees/images/retina.jpg, Copyright © The University 
of Melbourne 1994-2007).
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2.3 Rod and cone photoreceptors 
 and phototransduction
Rods and cones have the same basic structure: 
an outer segment and an inner segment 
connected by a narrow connecting cilium (Fig 
2A). The outer segments face the RPE and 
contain stacks of membrane disks fi lled with 
visual pigments. The visual pigments consist 
of a protein part, opsin, and a vitamin A derived 
chromophore, retinal. The visual pigment in rod 
photoreceptors is rhodopsin (Hargrave et al. 
1983). Cones have different visual pigments 
called cone opsins. Humans have three different 
cone opsins sensitive to different wavelengths 
of light (Nathans et al. 1986). L (or red) cones are 
maximally sensitive to long wavelengths of light, 
M (or green) cones to medium wavelengths, 
and S (or blue) cones to short wavelengths of 
light. The absorption of light photons by visual 
pigment molecules leads to a series of events, 
called phototransduction (Figure 2B), which 
eventually leads to closure of cation-specifi c 
channels and subsequent hyperpolarization 
of the plasma membrane and the signaling of 
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Figure 2A. Rod cell and rhodopsin molecule structure. The inner segment contains the metabolic 
machinery of a rod cell, whereas the outer segment is fi lled with rhodopsin-containing membrane 
disks. Rhodopsin is a member of G-protein coupled receptor family. It contains a protein part with 
seven transmembrane helices, and a chromophore, 11-cis-retinal. Image adapted from Hargrave 
and coworkers (1993). B. Details of phototransduction. The absorption of a light photon by rhodopsin 
leads to isomerization of the chromophore 11-cis-retinal to the all-trans form, and subsequent 
activation of rhodopsin. The activated rhodopsin (R*) stimulates G-protein, transducin, and causes 
the replacement of bound guanosine diphosphate (GDP) with guanosine triphosphate (GTP) in the 
transducin α-subunit. The α-subunit-GTP complex (T*α) then activates phosphodiesterase (PDE) 
by removing the inhibitory γ-subunits. Activated PDE (PDE*) catalyzes the hydrolysis of cyclic 
guanosine monophosphate (cGMP), which leads to closure of cGMP-activated cation channels 
and hyperpolarization of the cell membrane. After a photoresponse, the decreased intracellular 
calcium levels allow Ca2+ ions to dissociate from guanylate cyclase-activating protein (GCAP). 
Ca2+-free GCAP then activates guanylate cyclase (GC), which synthesizes cGMP for reopening 
the cation channels. A number of other proteins are required to deactivate other steps of the 
phototransduction cascade, and return rhodopsin to its inactive state, ready for absorption of 
another photon. Image adapted from Polans and coworkers (1996).
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second-order neurons by neurotransmitters 
(Pepe 2001).
The interaction of photoreceptors with the 
RPE is essential for visual function (Strauss 
2005). The RPE is composed of a single layer 
of cells that are densely packed with melanin 
pigment granules. It delivers nutrients to the 
photoreceptors, and transports ions, water 
and metabolic end products to the blood. 
To maintain photoreceptor excitability, RPE 
reisomerizes all-trans-retinal back into 11-cis-
retinal, stabilizes the ion composition of the 
subretinal space, and phagocytizes the tips 
of continuously renewing photoreceptor outer 
segments. The RPE also secretes growth 
factors that help to maintain the structural 
integrity of photoreceptors. Furthermore, it 
protects the retina against light-generated 
oxygen reactive species. 
2.4  Evaluating retinal function
A recording of electrical activity of retinal cells 
is called an electroretinogram (ERG). In ERG 
measurements, a low-resistance electrode is 
placed on the corneal surface and a reference 
electrode elsewhere on the head. The eye is 
then stimulated with a fl ash of light and the 
resulting voltage-changes are recorded with an 
oscilloscope. ERG can be used for evaluating 
retinal and visual function, and it is a very useful 
tool in clinical diagnosis. ERG is composed of 
three major components (Dowling 1987). The 
a-wave, which has negative polarity, originates 
from rod and cone photoreceptors. The 
following positive b-wave refl ects the activity 
of the inner retinal neurons, mainly depolarizing 
bipolar cells. With repetitive bright fl ashes 
oscillatory potentials, which originate from the 
amacrine cells, appear in the b-wave. A second, 
much slower positive component, the c-wave, 
is generated by the RPE. ERG can be measured 
in different conditions to separate rod- and 
cone-derived responses: under scotopic (i.e. 
dark-adapted) conditions ERG refl ects the 
function of rod photoreceptors whereas under 
photopic (i.e. light-adapted) conditions rods 
are bleached and only the function of cones is 
retained. 
3  Inherited retinal diseases
Taking into account the highly complex and 
sophisticated structure of the eye, it is not 
surprising that the eye is one of the most 
common sites of genetic diseases (Gregory-
Evans and Bhattacharya 1998). Diseases 
of the retina, such as age-related macular 
degeneration (AMD) and diabetic retinopathy, 
are especially important, being the leading 
causes of blindness in the Western world. 
Inherited retinal diseases, on the other hand, 
are the most common cause of vision loss 
among the working population in Western 
countries. It is estimated that ~1‰ of the 
people worldwide suffer from vision loss due 
to inherited retinal diseases, also known as 
retinal degenerations or retinal dystrophies. 
In Finland this adds up to over 5000 affected 
individuals (www.retina.fi ). The severity of 
these diseases varies from partial vision loss 
to total blindness. A growing body of data 
suggests that genetic factors also play a role 
in the development of the most common 
retinal disease, AMD (Patel et al. 2007). 
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3.1  Inheritance
To date, nearly 200 mapped loci, including 138 
cloned genes for inherited retinal diseases, have 
been identifi ed (Retinal Information Network, 
RetNet, www.sph.uth.tmc.edu/Retnet/home.
htm). The mode of inheritance can be autosomal 
dominant or recessive, X-linked dominant or 
recessive, digenic, mitochondrial, or complex. 
The genes associated with inherited retinal 
diseases are involved in many different cellular 
processes and functions, including visual 
transduction, retinoid cycle, regulation of gene 
expression, splicing, cellular traffi cking, and 
metabolic and structural functions (Gregory-
Evans and Bhattacharya 1998; Maubaret and 
Hamel 2005; Travis et al. 2007). The majority 
of the genes are retina-specifi c or retina-
enriched, but ubiquitously expressed genes 
may also cause “pure” retinal phenotypes 
(Blackshaw et al. 2001). In some cases, even 
genes that are not expressed in the retina may 
cause a retinal phenotype, as in the case of 
retinol binding protein, RBP4, which delivers 
retinol from the liver stores to the peripheral 
tissues (Seeliger et al. 1999). 
3.2  Exceptional heterogeneity
A striking feature in retinal diseases is the 
involvement of exceptional genetic, allelic, 
and clinical heterogeneity. Mutations in many 
different genes may cause the same disease, 
while different mutations in the same gene 
may cause different diseases. Furthermore, 
clinical features may be variable even among 
family members who carry the same mutation 
(Sullivan and Daiger 1996). A good example of 
genetic heterogeneity is retinitis pigmentosa 
(RP), with at least 47 mapped loci or identifi ed 
genes responsible for the phenotype (RetNet 
web page). Many of the disease genes also 
show vast allelic heterogeneity; for example 
mutations in ABCA4 lead to Stargardt disease 
(STGD) (Allikmets et al. 1997b) but may in 
addition cause RP (Cremers et al. 1998; 
Martinez-Mir et al. 1998), fundus fl avimaculatus 
(FFM, a late-onset subtype of STGD) (Rozet 
et al. 1998), AMD (Allikmets et al. 1997a), and 
cone-rod dystrophy (CRD) (Cremers et al. 
1998).
3.3  Development of clinical therapies
No effective treatments for inherited retinal 
diseases exist at the moment. The expanding 
knowledge about the molecular and genetic 
basis of these diseases is, however, continually 
improving the prospects for rational treatments. 
Active research is ongoing around a variety of 
intriguing treatment methods, including retinal 
cell transplantation and stem cells, artifi cial 
retinal implants, as well as growth factors and 
pharmaceutical therapies (www.blindness.
org). The most promising advance in the past 
few years has, however, been made in the 
development of gene therapy approaches. 
The eye can be considered as a good target 
for gene therapy, because it is accessible, 
easily examined by ophthalmoscopy, and the 
blood-retinal and blood-aqueous barriers help 
to target the vectors to the desired area without 
spreading out of the eye (Ali et al. 1997). The 
most effi cient gene delivery vehicles for 
treatment of retinal diseases are recombinant 
adeno-associated virus 2 (rAAV2) vectors, 
which achieve effi cient and stable gene 
transfer to RPE, photoreceptors, and ganglion 
cells (Auricchio and Rolling 2005). Convincing 
results were obtained recently when RPE65-/-
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briard dogs, with a retinal phenotype 
resembling that of Leber congenital amaurosis 
(LCA) in humans, were treated with rAAV2/4 
vector containing a human RPE65 promoter 
and cDNA. The targeted gene transfer in these 
dogs led to the stable restoration of normal 
retinal function and vision-dependent behavior 
(Le Meur et al. 2007). Clinical trials in humans 
have just begun, and may soon provide aid 
for children who have been born blind due 
to LCA, caused by RPE65 mutations (www.
clinicaltrials.gov).
 
3.4  Disease types
The genetic defect in inherited retinal diseases 
usually results in loss of photoreceptors (Travis 
1998). According to photoreceptor loss, these 
diseases can be broadly classifi ed into two 
types: those that initially affect rods in the 
peripheral retina, and those that initially affect 
cones in the central retina (Gregory-Evans 
and Bhattacharya 1998). In many disorders, 
however, both rod and cone systems are 
involved already in the early stages of the disease 
(Bird 1995). Diseases that start with peripheral 
vision loss are called rod-cone dystrophies. 
The most common disease type is RP, which 
is characterized by primary degeneration of rod 
photoreceptors, with secondary degeneration 
of cones (Hamel 2006). The earliest symptom 
is night blindness resulting from predominant 
rod involvement. As the disease progresses, 
initial peripheral vision loss evolves to ring 
shaped scotoma and eventually to tunnel 
vision. In later stages color vision may also 
be affected, and visual acuity decreases 
due to cone involvement. In contrast to rod-
cone dystrophies, central retinal dystrophies 
that include maculopathies as well as cone 
dystrophies (CDs) and cone-rod dystrophies 
refl ect the predominant involvement of cones, 
which leads to decreased visual acuity and loss 
of the central visual fi eld, while peripheral vision 
is retained for a longer time (Gregory-Evans and 
Bhattacharya 1998). Most frequently, retinal 
dystrophies are nonsyndromic, but there are 
some syndromes in which retinal degeneration 
is a characteristic feature. For example, in 
Usher syndromes sensorineural deafness 
is associated with typical RP (Boughman et 
al. 1983). Another example is Bardet-Biedl 
syndrome (BBS), which is characterized by 
retinal dystrophy, postaxial polydactyly, central 
obesity, mental retardation, hypogonadism, 
and renal dysfunction (Beales et al. 1999). 
3.5  Cone- and cone-rod dystrophies
Disorders with cone cell dysfunction can be 
classifi ed into two main categories: stationary 
and progressive disorders. Stationary cone 
dystrophies, better described as stationary 
cone dysfunction syndromes, are usually 
present already shortly after birth, and 
display normal rod function (Michaelides et 
al. 2004). Progressive cone dystrophies, on 
the other hand, appear in childhood or early 
adulthood, and may show variable extents 
of rod involvement (Michaelides et al. 2006). 
Thereby, progressive cone dystrophies show 
marked overlap with cone-rod dystrophies.  
Cone dystrophies and cone-rod dystrophies 
(prevalence 1:40,000) are a subgroup of 
inherited retinal degenerations characterized 
by initial loss of the cone system followed 
by variable degrees of rod degeneration 
(Hamel 2007; Michaelides et al. 2006). These 
diseases are usually discovered at school 
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age due to decreased visual acuity that does 
not signifi cantly improve with spectacles. 
Photophobia and color vision disturbances 
also appear at early stages resulting from 
primary cone involvement. In visual fi eld tests 
patients show central scotomas whereas 
the periphery is spared. Fundus examination 
usually reveals pigment deposits, macular 
atrophy, and pale optic discs. ERG shows 
affected cone or cone-rod responses. Due to 
initial loss of central vision patients try to project 
images onto the less damaged parafoveal 
region, resulting in a characteristic deviated 
gaze. As the disease progresses, visual acuity 
continues to decrease along with the loss 
of peripheral vision. Additionally, nystagmus 
and night blindness become more apparent. 
These diseases are clinically heterogeneous, 
and even family members with same mutation 
may show marked variation in disease severity 
(Downes et al. 2001; Michaelides et al. 2005). 
Histopathologic fi ndings indicate regional loss 
or reduced numbers of photoreceptors with 
shortened outer segments (Demirci et al. 2005; 
Rabb et al. 1986). RPE cells show accumulation 
of lipofuscin granules, and are atrophic or 
absent in the macular area. 
Like other inherited retinal degenerations, CDs 
and CRDs also show a vast genetic and allelic 
heterogeneity. The disease can be inherited 
in autosomal dominant, autosomal recessive, 
or X-chromosomal recessive manners. At 
least 22 genes are responsible for CD or CRD 
phenotypes, 20 on autosomes and 2 on the X-
chromosome (Table 1). Mutations in most of 
these genes may also lead to other inherited 
retinal degenerations. 
3.6  X-linked cone- and cone-rod 
 dystrophies
3.6.1 Clinical fi ndings
Patients with X-linked recessive cone- or 
cone-rod dystrophy (CORDX, formerly COD) 
show typical features of cone- and cone-rod 
dystrophies, including reduced visual acuity, 
photophobia, color vision defects, central 
scotomas, and affected cone or cone-rod 
responses in ERG (Brown et al. 2000; Hong 
et al. 1994; Jacobson et al. 1989; Meire et 
al. 1994; Mäntyjärvi et al. 2001; Pinckers 
and Timmerman 1981). Fundus fi ndings are 
nonspecifi c ranging from normal or subtle 
granularity of the macula, to bull’s eye lesions 
and central geographic atrophy of retinal 
pigment epithelium. In some patients a tapetal-
like sheen of the retina is also present (Brown 
et al. 2000; Heckenlively and Weleber 1986; 
Jacobson et al. 1989). In addition to the general 
features of cone and cone-rod dystrophies 
mentioned above, patients with X-linked forms 
of the disease often show moderate or high 
myopia. Nystagmus is usually absent. The 
disease begins in most cases within the fi rst 
two decades of life and progresses gradually, 
however, the phenotypic expression of the 
disease varies with respect to age of onset and 
severity of symptoms (Brown et al. 2000; Hong 
et al. 1994; Jacobson et al. 1989; Mäntyjärvi 
et al. 2001). Additionally, female carriers show 
variable expression of the disease, ranging 
from clinically asymptomatic to mild impairment 
of visual acuity, light sensitivity, and slight 
abnormalities in color vision, ophthalmoscopy, 
and ERG (Brown et al. 2000; Hong et al. 1994; 
Jacobson et al. 1989; Meire et al. 1994; 
Mäntyjärvi et al. 2001).
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ad, autosomal dominant; ar, autosomal recessive; xl, X-linked; ACHM, achromatopsia; AMD, 
age-related macular degeneration; CD, cone dystrophy; CRD, cone-rod dystrophy; FFM, 
fundus fl avimaculatus; LCA, Leber congenital amaurosis; MD, macular dystrophy; RP, retinitis 
Table 1. Identifi ed genes and mapped loci responsible for cone- and cone-rod dystrophies
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3.6.2  Molecular genetics
CORDX is a genetically heterogeneous 
disorder, with two loci, CORDX1 (formerly 
COD1, MIM 304020) and CORDX2 (formerly 
COD2, MIM 300085), localized by the time 
this thesis work started. CORDX1, located on 
Xp21.1-p11.4 (Bergen et al. 1993; Hong et al. 
1994; Seymour et al. 1998), is now known to 
be caused by mutations in an alternative 3’ 
exon of the RPGR gene (Xp21.1, MIM 312610) 
(Demirci et al. 2002; Yang et al. 2002). RPGR 
was fi rst identifi ed as a causative gene for RP 
(Meindl et al. 1996; Roepman et al. 1996). The 
discovery of the new alternative 3’ RPGR exon, 
called open reading frame (ORF) 15, revealed 
a mutational hotspot (Vervoort et al. 2000). 
A total of 55% of the RPGR mutations identifi ed 
to date are located in exon ORF15, most likely 
due to insertions and deletions resulting from 
the highly repetitive nature of this region (Shu et 
al. 2007). In addition to RP and CORDX, RPGR 
mutations may also cause atrophic macular 
dystrophy (Ayyagari et al. 2002), and RP with 
hearing loss and chronic infections (Zito et al. 
2003). The other CORDX locus, CORDX2, 
maps between markers DXS292 and DXS1113 
on Xq27-q28, based on linkage analysis in a 
family with X-linked progressive cone dystrophy 
(Bergen and Pinckers 1997), but the disease-
causing gene remains to be identifi ed.
pigmentosa; STGD, Stargardt disease; ERG, electroretinogram; 1, (Allikmets et al. 1997a); 2, 
(Allikmets et al. 1997b); 3, (Cremers et al. 1998); 4, (Martinez-Mir et al. 1998); 5, (Rozet et al. 
1998), 6, (Beharry et al. 2004); 7, (Khaliq et al. 2000); 8, (Ismail et al. 2006); 9, (Kumanogoh et 
al. 2002); 10, (Rice et al. 2004); 11, (Abid et al. 2006); 12, (Subbaraya et al. 1994); 13, (Payne et 
al. 1998); 14, (Downes et al. 2001); 15, (Farrar et al. 1991); 16, (Kajiwara et al. 1991); 17, (Travis 
et al. 1991); 18, (Kajiwara et al. 1993); 19, (Nichols et al. 1993); 20, (Kajiwara et al. 1994); 21, 
(Apfelstedt-Sylla et al. 1995); 22, (Nakazawa et al. 1996); 23, (Felbor et al. 1997); 24, (Coppola et 
al. 2001); 25, (Johnson et al. 2003); 26, (Danciger et al. 2001); 27, (Kohl et al. 2000); 28, (Sundin 
et al. 2000); 29, (Michaelides et al. 2004); 30, (Nishiguchi et al. 2005); 31, (Ottschytsch et al. 
2002); 32, (Wu et al. 2006); 33, (Qin et al. 2002); 34, (Wycisk et al. 2006); 35, (Simon et al. 1996); 
36, (Yamamoto et al. 1999); 37, (Nakamura et al. 2000); 38, (Nakamura et al. 2003); 39, (Hayashi 
et al. 2006); 40, (Dryja et al. 2001); 41, (Hong et al. 2001); 42, (Hameed et al. 2003); 43, (Booij et 
al. 2005); 44, (Shyjan et al. 1992); 45, (Perrault et al. 1996); 46, (Kelsell et al. 1998); 47, (Ocaka et 
al. 2005); 48, (Köhn et al. 2007); 49, (Sohocki et al. 2000a); 50, (Sohocki et al. 2000b); 51, (Liu 
et al. 2004); 52, (van der Spuy and Cheetham 2004); 53, (Kobayashi et al. 2000); 54, (Gorska et 
al. 2004); 55, (Kylstra and Aylsworth 1993); 56, (Warburg et al. 1991); 57, (Wang et al. 2004); 58, 
(Freund et al. 1997); 59, (Swain et al. 1997); 60, (Freund et al. 1998); 61, (Sohocki et al. 1998); 62, 
(Meindl et al. 1996); 63, (Ayyagari et al. 2002); 64, (Demirci et al. 2002); 65, (Yang et al. 2002); 66, 
(Zito et al. 2003); 67, (Khanna et al. 2005); 68, (Shu et al. 2005); 69, (Bergen and Pinckers 1997). 
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3.7  Åland Island eye disease (AIED)
3.7.1 Clinical fi ndings
Åland Island eye disease (AIED), also referred 
to as Forsius-Eriksson syndrome, or Forsius-
Eriksson type (type II) ocular albinism (MIM
300600), was fi rst described in 1964 in 
a farmer’s family on the Åland Islands in 
southwestern Finland (Forsius and Eriksson 
1964). In addition to the original AIED family, 
a few families with a similar phenotype, 
referred to as AIED-like disease, have been 
described (Carlson et al. 1991; Glass et al. 
1993; Hawksworth et al. 1995; Rosenberg 
et al. 1990). AIED is characterized by fundus 
hypopigmentation, decreased visual acuity 
due to foveal hypoplasia, latent nystagmus, 
astigmatism, red color vision defect, progressive 
axial myopia, and defective dark adaptation 
(Carlson et al. 1991; Forsius and Eriksson 1964; 
Waardenburg 1970). In ERG, both scotopic 
and photopic functions are affected (Carlson 
et al. 1991). Except for progression of myopia, 
and secondary color vision disturbances in 
older individuals, the disease is considered to 
be stationary (van Dorp et al. 1985). Female 
carriers of the disease are clinically normal, 
except for slight latent nystagmus in some 
cases (van Vliet et al. 1973).
On the basis of fundus hypopigmentation, AIED 
was originally regarded as a variant of ocular 
albinism. The absence of macromelanosomes 
in skin melanocytes (O’Donnell et al. 1980), 
and latent nystagmus of extraocular origin 
(van Vliet et al. 1973) indicated, however, that 
AIED is distinct from Nettleship-Falls type 
ocular albinism (MIM 300500). Misrouting 
of the optic nerve fi bers, present in persons 
with albinism, was also absent in a patient 
with AIED (van Dorp et al. 1985). The fundus 
hypopigmentation in AIED patients presumably 
results from stretching and thinning of RPE due 
to the progression of axial myopia (van Dorp et 
al. 1985). 
3.7.2 Similarity of AIED to congenital 
 stationary night blindness (CSNB2)
AIED shows notable clinical similarities to 
another inherited retinal disease, congenital 
stationary night blindness (CSNB). X-linked 
CSNB (CSNBX) is a nonprogressive retinal 
disease characterized by impaired night 
vision, myopia, nystagmus, strabismus, and 
reduced visual acuity (Pearce et al. 1990). The 
expression of the disease is variable, and at 
least one of the main symptoms is often absent 
(Boycott et al. 2000; Pearce et al. 1990). ERG 
in CSNBX patients is of Scubert-Bornschein 
type (or “negative”), which means that the 
amplitude of the rod-derived a-wave is larger 
than the postsynaptic b-wave under scotopic 
testing conditions (Schubert and Bornschein 
1952). Two forms of CSNBX are distinguished 
based on the ERG fi ndings. The complete type 
of CSNBX (type 1, CSNB1) is characterized by 
a lack of detectable scotopic b-waves, whereas 
in the incomplete type (type 2, CSNB2) the 
scotopic b-wave is present but diminished 
(Miyake et al. 1986; Tremblay et al. 1995). The 
photopic cone responses are also affected, 
and often more impaired in the incomplete 
type. Evidence consistent with the clinical 
subdivision came as the genetic background 
of CSNBX was resolved. Mutations in the NYX 
gene (Xp11.4, MIM 300278) are responsible 
for CSNB1 (MIM 310500) (Bech-Hansen et 
al. 2000; Pusch et al. 2000), whereas CSNB2 
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(MIM 300071) results from mutations in the 
L-type calcium channel α1-subunit gene, 
CACNA1F (Xp11.23; MIM 300110) (Bech-
Hansen et al. 1998; Strom et al. 1998).
3.7.3  AIED mapping studies
Based on the clinical similarities between AIED 
and CSNBX, researchers have long discussed 
whether these two diseases might be allelic or 
even form a single entity (Krill 1977; Weleber 
et al. 1989). Linkage studies of the original 
AIED family supported this idea by localizing 
the AIED gene locus between markers MAOA 
and DXS559 in the Xp11.3-q13.1 region (Alitalo 
et al. 1991; Alitalo et al. unpublished linkage 
data), which overlapped with the CSNB2 
genetic interval. After the genetic background 
of CSNBX was disclosed, mutation analyses 
of the CACNA1F gene, responsible for 
CSNB2, were carried out also in AIED families. 
Sequencing experiments revealed disease-
causing mutations in patients with an AIED-
like phenotype, however, efforts to reveal 
CACNA1F mutations in patients of the original 
AIED family were unsuccessful (Wutz et al. 
2002).  
4  Voltage-dependent 
 calcium channels 
Intracellular calcium levels are tightly regulated 
in eukaryotic cells during normal cell functions. 
In resting cells, the cytoplasmic free calcium 
concentration is much lower than in the 
extracellular environment, mainly due to the 
Ca2+-impermeable cell membranes, and active 
transport of Ca2+ into intracellular organelles 
(especially the endoplasmic reticulum) as well 
as across the plasma membrane (Yamakage 
and Namiki 2002). A transient increase in 
calcium permeability results in Ca2+ infl ux into 
the cell down its electrochemical gradient. 
Calcium entry into the cell occurs through ion 
channels. Ion channels are transmembrane 
proteins that form selective pores across 
the lipid bilayer allowing inorganic ions of 
appropriate size and charge to cross the 
membrane (Alberts et al. 2002). Channels are 
not continuously open, instead, they are gated. 
Based on the stimulus that may open the 
“gate”, ion channels are subdivided into three 
main types: mechanically gated channels, 
opened by mechanical stress (Orr et al. 2006), 
ligand-gated channels, opened by the binding 
of a ligand (Connolly and Wafford 2004), and 
voltage-gated channels, opened by a change 
in membrane potential (Bezanilla 2005). 
The voltage-dependent calcium channels 
(VDCCs) are a group of voltage-gated 
channels found in many nonexcitable cells and 
all excitable cell types (such as neurons and 
muscle cells), where they serve as transducers 
of electrical signals into changes in intracellular 
Ca2+ levels (Felix 2005). In the cell, Ca2+ acts 
as a second messenger, activating many 
crucial intracellular events including muscle 
contraction, hormone secretion, synaptic 
transmission, or gene expression, depending 
on the cell type (Catterall 2000).
4.1  Functional diversity
According to the physiological and 
pharmacological properties of Ca2+ currents, 
VDCCs are subdivided into multiple classes 
(Table 2) (Catterall 2000; Catterall et al. 2005). 
L-type channels mediate long-lasting currents, 
which require strong depolarization for 










Cav1.1 L HVA α1S CACNA1S DHPs Skeletal muscle Excitation-
contraction
coupling





















Cav1.4 L HVA α1F CACNA1F DHPs Retina Neurotransmitter 
release 
from photoreceptors



















Cav2.3 R HVA/IVA α1E CACNA1E SNX-482 Neurons Repetitive fi ring, 
dendritic Ca2+ 
transients








Cav3.3 T LVA α1I CACNA1I none Neurons Pacemaking, 
repetitive fi ring
Table 2. Characteristics of voltage-dependent calcium channel subtypes 
  (modifi ed from Catterall et al. 2005)
HVA, high voltage-activated, IVA, intermediate voltage-activated; LVA, low voltage-activated; DHPs, 
dihydropyridines. *Gene coding for the α1-subunit, which determines the channel subtype.
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activation and show large single-channel 
conductance, slow voltage-dependent 
inactivation, regulation by cAMP-dependent 
phosphorylation, and sensitivity to organic Ca2+ 
antagonist drugs including dihydropyridines, 
phenylalkylamines and benzothiazepines. T-
type currents, on the other hand, are transient 
currents that activate at low voltages, inactivate 
rapidly, deactivate slowly, have small single-
channel conductance, and are insensitive to 
both Ca2+ antagonist drugs and polypeptide 
toxins from snail and spider venoms. Like L-
type currents, N-type, P/Q-type, and R-type 
currents also require strong depolarization 
for activation. They are, however, relatively 
insensitive to organic Ca2+ antagonist drugs, 
but are defi ned by specifi c snail and spider 
toxins that block them. Based on the voltage-
activation threshold, these fi ve channel types 
can be divided into two classes: high voltage-
activated channels (HVA) and low voltage-
activated channels (LVA). Sometimes a third 
group, intermediate voltage-activated (IVA) 
channels, is also mentioned (Yamakage and 
Namiki 2002).
4.2  Molecular composition
HVA calcium channels are hetero-oligomeric 
protein complexes composed of three to 
four subunits, α1, α2δ, β, and in some cases γ. 
(Figure 3) (Catterall 2000). The α1-subunit is a 
multi-spanning membrane protein that forms 
an aqueous pore to the lipid bilayer (Jurkat-
Rott and Lehmann-Horn 2004). The protein is 
organized into four repeat domains (I-IV) each 
containing six transmembrane domains (S1-S6). 
The segments S5 and S6 and the membrane 
associated loop between them form the pore 
lining, whereas S4 serves as the voltage sensor 
initiating conformational changes that open the 
channel. In addition to constituting the channel 
pore, voltage-sensor and gating apparatus, 
the α1-subunit determines the main binding 
sites for regulatory agents, including second 
messengers, drugs and toxins (Catterall et al. 
2005). 
The β-subunit is a cytoplasmic protein that 
binds to the α1-subunit at the α1 interaction 
domain (AID) on the I-II linker region (Richards 
et al. 2004). Multiple interactions between 
α1- and β-subunits are crucial for regulation 
mediated by the β-subunit, including traffi cking 
of the channel complex to the cell membrane, 
and modulating the channel gating properties 
(Maltez et al. 2005). 
The α2δ-subunit is a heavily glycosylated 
protein derived from a common precursor by 
proteolytic cleavage to α2- and δ-peptides, 
which remain linked to each other by disulfi de 
bridges (Davies et al. 2007). The α2-subunit is 
extracellular and interacts with α1, whereas δ 
has a single transmembrane segment, which 
anchors the protein to the cell membrane 
(Gurnett et al. 1997). The α2δ-subunit acts as 
a channel modulator by enhancing traffi cking of 
the channel complex to the plasma membrane 
(Canti et al. 2005), and regulating the bio-
physical properties of the channel, including 
activation and inactivation kinetics and voltage-
dependence (Felix et al. 1997). 
The γ-subunit is a four transmembrane domain 
glycoprotein, originally detected only in skeletal 
muscle VDCCs (Jay et al. 1990), but recently 
indicated to associate also with neuronal P/Q- 
and N-type channels (Kang et al. 2001). The 
main function of the γ-subunit is to modulate 
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the biophysical properties of the channel, but 
unlike other accessory subunits, the γ-subunit 
does not seem to have a signifi cant role in 
traffi cking of the channel complex to the cell 
membrane (Arikkath et al. 2003). In addition 
to modulation of HVA calcium currents in 
skeletal muscle and neurons, the γ-subunit 
may have other biological functions, such as 
regulation of α-amino-3-hydroxyl-5-methyl-
4-isoxazolepropionate (AMPA) receptor 
membrane targeting (Chen et al. 2000). The 
molecular composition of the LVA calcium 
channel accessory subunits is less clear.
 
4.3  Calcium channel genes
The functional diversity of VDCCs is generated 
both by multiple genes and by alternative splicing 
of RNA transcripts. Mammalian α1-subunits are 
encoded by at least ten distinct CACNA1 genes 
(Table 2). Amino acid sequence comparisons 
of protein products of the α1-subunit genes 
defi ne three subfamilies, Cav1, Cav2, and Cav3, 
with intra-family sequence identities above 
70% (Catterall et al. 2005). Calcium channel 
α1-subunit diversity is enhanced by alternative 
splicing of pre-mRNA. Genes for α1-subunits 
are well conserved at coding regions for 
transmembrane segments S1-S5, but the 
remaining regions are less conserved and show 
variable degrees of alternative splicing (Jurkat-
Rott and Lehmann-Horn 2004). The diversity 
of Ca2+ channel structure and function is further 
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Figure 3. Molecular composition of VDCC purifi ed from skeletal muscle: a pore-forming α1-
subunit of 190 kDa is associated with a disulphide-linked α2δ-dimer of 170 kDa, an intracellular 
β-subunit of 55 kDa, and a transmembrane γ-subunit of 33 kDa. Cylinders indicate alpha-helices 
and branched lines in α2δ- and γ-subunits represent sugar units. PM, plasma membrane. Modifi ed 
from Catterall et al. (2000).
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Four distinct β-subunit genes, CACNB1-
CACNB4, have been identifi ed (Birnbaumer et 
al. 1998). Amino acid sequence comparisons 
between the β-subunits reveal fi ve domains 
D1-D5 (Birnbaumer et al. 1998). Two of the 
domains (D2 and D4) exhibit high homology 
among the four β-subunits, and resemble the 
SH3 fold (D2) and guanylate kinase fold (D4) 
of membrane-associated guanylate kinase 
(MAGUK) proteins (McGee et al. 2004). The 
amino terminus (D1), small central linker (D3), 
and carboxy terminus (D5), are less conserved 
and undergo extensive alternative splicing 
(Foell et al. 2004). Recently, new short splice 
variants were described, which lack large 
regions of the central conserved domains 
but still yield functional channel complexes 
(Harry et al. 2004). At least four distinct 
genes, CACNA2D1-CACNA2D4, encode 
the α2δ-subunits (Qin et al. 2002). Alternative 
splicing have been described for CACNA2D1 
(Angelotti and Hofmann 1996), CACNA2D2 
(Hobom et al. 2000), and CACNA2D4 (Qin et 
al. 2002). The γ-subunit gene family consists 
of eight members, CACNG1-CACNG8 (Kang 
and Campbell 2003). The γ-subunit is the 
least studied calcium channel subunit, and 
alternative splicing has reported only for 
CACNG6 (Burgess et al. 2001; Chu et al. 
2001). 
Many cells may express several subtypes of 
distinct subunits, and for example, distinct β- 
and α2δ-subunits can interact promiscuously 
with α1-subunits (Dalton et al. 2005; Klugbauer 
et al. 2003). Functionally diverse calcium 
channels are presumably formed from different 
combinations of α1-, α2δ-, β-, and γ-subunits, 
but the physiological role of the different 
combinations is still unclear (Qin et al. 2002).
4.4  Calcium channelopathies
Mutations in the genes encoding VDCC 
subunits in humans result in a variety of inherited 
diseases or “channelopathies”. Mutations in 
the CACNA1A gene encoding the α1-subunit 
of neuronal P/Q-type calcium channel Cav2.1, 
cause familial hemiplegic migraine type 1 
(FHM1), episodic ataxia type 2 (EA2), and 
spinocerebellar ataxia type 6 (SCA6) (Ophoff 
et al. 1996; Zhuchenko et al. 1997). Mutations 
in the CACNA1C gene encoding the L-type 
Cav1.2 channel α1-subunit are associated with 
Timothy syndrome (long QT syndrome 8), which 
is characterized by multiorgan dysfunction, 
including lethal arrhythmias, webbing of 
fi ngers and toes, congenital heart disease, 
immune defi ciency, intermittent hypoglycemia, 
cognitive abnormalities, and autism (Splawski 
et al. 2004), or Brugada syndrome (short QT 
syndrome) causing sudden cardiac death 
(Antzelevitch et al. 2007). CACNA1S mutations 
of the skeletal muscle L-type Cav1.1 α1-subunit 
may result in hypokalemic periodic paralysis 
(HPP1) characterized by hypotonia and muscle 
weakness (Ptacek et al. 1994) or malignant 
hyperthermia susceptibility (MHS) triggered by 
anesthetics or depolarizing muscle relaxants 
(Monnier et al. 1997). Mutations of the T-
type Cav3.2 channel α1-subunit encoded 
by CACNA1H are implicated in childhood 
absence epilepsy (Chen et al. 2003), whereas 
a variant of the R-type Cav2.3 channel α1-
subunit is suggested to associate with type 
2 diabetes (Li Muller et al. 2007). VDCCs 
are upregulated in many cancer cells, and 
their role in the progression of cancer (cell 
proliferation, differentiation and motility) is 
currently under active investigation (Fiske et al. 
2006). Mutations in the auxillary subunits may 
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lead to similar phenotypes as those caused by 
α1-subunit mutations; CACNB4 encoding β4-
subunit is associated with epilepsy and ataxia 
(Escayg et al. 2000), whereas mutations of 
CACNB2 encoding the β2-subunit are involved 
in Brugada syndrome (Antzelevitch et al. 
2007).
VDCCs also have a role in the development of 
several retinal diseases. As mentioned earlier, 
mutations in CACNA1F encoding the retinal L-
type Cav1.4 α1-subunit lead to X-linked recessive 
retinal disease, CSNB2 (Bech-Hansen et al. 
1998; Strom et al. 1998). In addition to CSNB2, 
several other retinal diseases are shown to 
associate with CACNA1F mutations, including 
AIED-like phenotype (Wutz et al. 2002), retinal 
and optic disc atrophy with progressive decline 
of visual function (Nakamura et al. 2003), and 
severe CSNB2-like phenotype associated 
with female carrier symptoms and intellectual 
disability (Hope et al. 2005). Recently, mutations 
in one of the auxillary subunits, α2δ4 encoded 
by CACNA2D4, were also shown to lead to a 
retinal phenotype in a family with autosomal 
recessive cone dystrophy (Wycisk et al. 2006). 
A number of spontaneous or engineered 
mutations in mouse VDCC subunit genes have 
been related with many neuronal, muscular, 
and retinal phenotypes in mice (Felix 2006). 
Two different CACNA1F mutant mice exist, 
both displaying retinal dysfunction similar 
to CSNB2 in humans (Chang et al. 2006; 
Mansergh et al. 2005). β2-subunit null mice 
expressing the rat β2-subunit in cardiac muscle 
also display a retinal phenotype similar to 
CSNB2 (Ball et al. 2002). No human β2-subunit 
mutations have, however, been described in 
CSNB patients. Complete β2-subunit gene 
null mutations are lethal in mice because of 
lack of cardiac contraction (Ball et al. 2002), 
which is consistent with the fi nding that human 
β2-subunit mutations are reported to cause 
sudden cardiac death (Antzelevitch et al. 2007). 
Information on possible retinal dysfunction in 
cardiac patients carrying β2-subunit mutation is 
unavailable. The discovery and careful analysis 
of mouse models will help to clarify the role of 
different mutations in calcium channel function 
and the pathogenesis of associated diseases 
(Felix 2006).
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AIMS OF THE STUDY
Prior to this thesis work, two X-linked cone-rod dystrophy loci had been localized, CORDX1 to 
Xp21.1-11.4 (Bergen et al. 1993; Hong et al. 1994; Seymour et al. 1998) and CORDX2 to Xq27-28 
(Bergen and Pinckers 1997). The disease gene for Åland Island eye disease had been localized to 
Xp11.3-q13.1 (Alitalo et al. 1991; Alitalo et al. unpublished linkage data). During the course of the 
study, the RPGR gene was identifi ed as a causative gene for CORDX1 (Demirci et al. 2002; Yang et 
al. 2002). This study was conducted to clarify the genetic background of X-linked retinal diseases. 
The specifi c objectives of this study were to determine:
1.  the X-chromosomal location of the cone-rod dystrophy locus (CORDX3) in a Finnish family
2.  the genes responsible for CORDX3 and Åland Island eye disease
3.  mutations in the newly-identifi ed disease gene (CACNA1F) in other patients with related 
 retinal phenotypes
4. the functional consequences of the newly-identifi ed disease gene (CACNA1F) mutations
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MATERIAL AND METHODS
1  Subjects and samples
1.2  Consent and ethics committee   
 permissions
The patients and family members were informed 
about the aims of these studies. All participants 
signed an informed consent form before blood 
samples were collected. Appropriate research 
permissions were obtained from the Ethics 
committees of the participating hospitals.
1.3 Cone-rod dystrophy (CORDX) patients
Members of a large six-generation Finnish 
family with X-linked cone-rod dystrophy 
(CORDX) were included in linkage (Study I) 
and mutation (Study II) analyses. The detailed 
clinical fi ndings of this family have been 
published earlier by Mäntyjärvi and coworkers 
(2001). Briefl y, in most of the patients (8/10) 
of this family the onset of the disease was in 
childhood, whereas some (2/10) developed 
the disease clearly in adulthood. All affected 
males showed decreased visual acuity, myopic 
refraction, red or red-green color vision defects, 
elevated or missing cone thresholds and 
elevated rod thresholds in dark adaptation, and 
affected cone or cone-rod responses in ERG. 
Visual fi elds were normal or concentrically 
constricted. Some patients had also central 
scotomas or central reduced sensitivity in the 
visual fi eld. None of the patients had bull’s eye 
lesions in their eye fundi, but myopic changes 
or irregular pigmentation in the macular area 
was present. The 12-14 year follow-up study 
of four patients revealed only slow progression 
of the disease including refractional changes, 
and mild deterioration in visual acuity, color 
vision, and visual fi elds. Female carriers of the 
family were clinically normal. A total of 50 family 
members, including 7 affected males, provided 
blood samples for genetic studies. The Family 
Federation of Finland and the Department of 
Ophthalmology, University of Kuopio, organized 
the collection of the samples.
1.4 Åland Island eye disease (AIED) patients
Members of the original seven-generation 
AIED family were included in Study III. The 
disease gene of the family had been mapped 
earlier to Xp11.3-q13.1 between markers 
MAOA and DXS559 (Alitalo et al. 1991; Alitalo 
et al. unpublished linkage data). DNA samples 
from 29 family members with 6 affected males 
were included in the mutation analysis. The 
phenotype of the affected males is described 
in Forsius and Eriksson (1964), Waardenburg 
(1970), van Vliet and coworkers (1973), and 
Carlson and coworkers (1991). Briefl y, affected 
males had hypopigmented fundi, decreased 
visual acuity due to foveal hypoplasia, latent 
nystagmus, astigmatism, red color vision 
defects, and progressive axial myopia. Dark 
adaptation curves were subnormal with 
elevated thresholds. In ERG, both rod and cone 
mediated responses were affected. Female 
carriers did not show any features of the 
disease, except for slight latent nystagmus in 
some cases.
1.5  CSNB2 patient
During the course of the study DNA samples 
from members (an affected male and his 
mother) of another Finnish family were included 
in mutation analysis (unpublished experiments 
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[U]). The patient was diagnosed with CSNB at 
the age of 9. He had congenital nystagmus, 
severe photophobia, progressive myopia, 
astigmatism, and his best corrected visual 
acuity was reduced, 0.1–0.2 in both eyes (-6.0 
cyl +1,5 ax 110//-6.0 cyl +1,5 ax 70). His optic 
discs were pale, and the ocular fundi were 
hypopigmented, however, there was normal 
or slight hyperpigmentation in the maculas, 
and the foveas seemed normal. The dark 
adaptation was delayed with missing cone 
threshold and elevated rod threshold, and the 
ERG was negative. Due to photophobia and 
nystagmus, the quality of the ERG was not good 
enough to distinguish between the complete 
or incomplete types of CSNB. As the patient 
had some clinical features in common with the 
phenotype of the Finnish CORDX family, the 
disease gene of the Finnish CORDX family was 
a likely candidate for the defective gene in this 
family. In the following sections this family is 
referred to as the CSNB2 family.
1.6  Control samples
DNA samples from 121 Finnish male blood 
donors and 50 unrelated, healthy Canadian 
females, and RNA samples extracted from nine 
lymphoblastoid cell lines of unrelated, healthy 
Finnish males and females served as controls. 
1.7  Cell lines
 
Epstain-Barr virus–transformed lymphoblastoid 
cell cultures from two patients of the CORDX 
family, the patient of the CSNB2 family, a 
patient of the AIED-family, and from nine 
unrelated controls were used in splicing 
studies (II, III, U). Activated peripheral blood T-
lymphocytes from a patient and a carrier of the 
CORDX family, and from an unrelated control 
were utilized in splicing experiments as well (II). 
Commercially available African green monkey 
kidney cells (COS-1), baby hamster kidney cells 
(BHK-21), and human embryonic kidney cells 
(HEK-293) from the American Type Culture 
Collection (ATCC) were used in the functional 
experiments (U).
2  Methods
2.1  DNA and RNA extraction (I, II, III, U)
Genomic DNA from peripheral blood leucocytes 
was extracted by a standard nonenzymatic 
method (Lahiri and Nurnberger 1991) (I) or with 
the Gentra Puregene Blood Kit (Qiagen GmbH, 
Hilden, Germany) (U). RNA was extracted from 
cultured lymphoblastoid cells with the RNeasy 
Mini Kit (Qiagen) (II, III) or the RNAqueous -
4PCR Kit (Ambion Inc., Austin TX, USA) (U), and 
from activated peripheral blood T-lymphocytes 
with Trizol reagent (Invitrogen, Burlington, ON, 
USA) (II). Isolated RNA was treated with DNAse 
(MessageClean Kit, GeneHunter, Nashville, 
TN, USA or from the RNAqueous -4PCR Kit, 
Ambion Inc.) to remove contaminating DNA, or 
used directly as a template for fi rst strand cDNA 
synthesis.
2.2  Polymorphic markers (I)
A total of 39 polymorphic markers, utilized in 
linkage analysis (I), covered the region Xp22.32-
Xq28 (See Results, Figure 4). Two of these 
markers were SNPs located in RPGR gene 
introns (rs3888228 and SNP1), and 37 were 
microsatellite markers, mostly dinucleotide 
repeats. Two of the repeats, CA20 and CA23, 
were novel markers identifi ed from the National 
Material and methods
36
Center for Biotechnology Information (NCBI, 
www.ncbi.nlm.nih.gov) database sequence 
(AC006121). Information on DXS10042 was 
obtained from Dr. Torben Bech-Hansen, and 
the other 34 known markers were from the 
NCBI UniSTS database. 
2.3 Gel electrophoresis (PAGE, SSCP) (I)
PCR-amplifi ed alleles of the microsatellite 
markers were fractionated in 6% polyacrylamide 
(PAGE) gels (National Diagnostics, Atlanta, 
GA, USA). Single-strand conformation poly-
morphism (SSCP) gel electrophoresis was 
applied to separate the RPGR gene SNP 
alleles used in linkage analysis, and to screen 
the candidate genes (DDX3, NYX, GPR34, I-4, 
NDP, RP2, TIMP1, and ARR3) for mutations. 
Exons and the genomic regions containing 
SNPs were PCR-amplifi ed from genomic DNA, 
after which the PCR products were separated 
on 0.5-1.0 x MDE gels (BioWhittaker Molecular 
Applications, Rockland, ME, USA). PAGE- and 
SSCP-gels were visualized by silver staining 
(Bassam et al. 1991).
2.4 Linkage and haplotype analysis (I)
For linkage and haplotype analyses, 50 family 
members of the CORDX family were genotyped 
with the 39 X-chromosomal markers. Haplo-
types were constructed manually. Linkage 
analysis was carried out using the MLINK 
program of the FastLink package, version 
4.1P (Cottingham et al. 1993). The inheritance 
mode was set to X-linked with full penetrance, 
assuming disease allele frequency of 
0.00001. Allele frequencies for the markers 
were calculated from the unaffected family 
members.
2.5  Sequencing (I, II, III, U)
Candidate genes (DDX3, NYX, GPR34, I-4, NDP, 
RP2, TIMP1, ARR3, RPGR [I], and CACNA1F 
[II, III, U]) were screened for mutations by 
direct DNA sequencing. Exons and exon-
intron boundaries of the genes were PCR-
amplifi ed from genomic DNA. Primers were 
designed with the Primer 3 program (http://
frodo.wi.mit.edu/primer3/input.htm). For the 
CACNA1F gene, published primer sequences 
were used (Boycott et al. 2001). PCR-products 
were purifi ed either with the QIAquick PCR 
Purifi cation Kit (Qiagen), or with ExoSAP-IT 
(USB, Cleveland, OH, USA), and sequenced 
with the ABI PRISM BigDye Terminator v3.0/
v3.1 Cycle Sequencing Kit and the ABI310 
Genetic Analyzer (Applied Biosystems, Foster 
City, CA, USA). 
2.6  mRNA/cDNA analysis (II, III, U)
 
Reverse transcriptase polymerase chain 
reaction (RT-PCR) was used to assess the 
naturally occurring CACNA1F mRNA splice 
variants, and aberrant variants caused by 
CACNA1F mutations. Human retinal cDNA 
(Human Retina QUICK-Clone cDNA library; 
BD-Clontech, Palo Alto, CA, USA), and 
lymphoblastoid/T-cell cDNA, synthesized with 
M-MLV (H-) enzyme and random hexamers 
(Promega, Madison, WI, USA) (II, III, U), or with 
Omniscript RT Kit (Qiagen) (II), were used 
as templates in PCR with CACNA1F exonic 
primers. Primers for cDNA studies were 
designed with the Primer 3 program. 
The regions studied from CACNA1F cDNA 
were the following: the sequence from exons 
27-28 to exons 33-34 was studied from 
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retinal cDNA, cDNA from activated T-cells 
of a CORDX patient, a carrier female and an 
unrelated control, and from lymphoblastoid 
cDNA of two CORDX patients, an AIED patient, 
and nine unrelated controls (II, III). The exon 14-
18 region was studied from the patient of the 
CSNB2 family and an unrelated control (U). The 
region of interest was PCR-amplifi ed from the 
cDNA. Three approaches were then applied 
to separate the different sized PCR-products. 
First, PCR-fragments were separated on 1-
2% Metaphor agarose gels (BioWhittaker 
Molecular Applications), excised, and column 
purifi ed (Qiagen). Second, PCR-products 
were fractionated on 6% PAGE gels, excised, 
reamplifi ed, and column purifi ed (Qiagen). Third, 
PCR-products were cloned into the pCR2.1-
TOPO cloning vector (Invitrogen, Carlsbad, 
CA, USA), and plasmids were extracted with 
the Plasmid Mini Kit (Qiagen). Purifi ed DNA-
fragments and plasmids were then sequenced 
with the ABI310 Genetic Analyzer (Applied 
Biosystems).
2.7  Restriction fragment length poly-  
 morphism (RFLP) (II, U)
RFLP analysis was utilized to screen the 
CACNA1F mutations, IVS28-1 GCGTC>TGG 
(II) and IVS16+2T>C (U), among the family 
members and control samples. The region of 
interest was PCR amplifi ed and then digested 
either with restriction endonuclease (New 
England Biolabs, Beverly, MA, USA) Fnu4HI 
(IVS28-1 GCGTC>TGG) or with HpyCH4III 
(IVS16+2T>C). Digested PCR-products were 
run on 2% agarose gels and visualized with 
ethidium bromide under UV light.
2.8  In vitro expression of the Cav1.4   
 calcium channel (U)
Subcellular localization of the Cav1.4 channel 
was studied by transient transfections (U). 
Expression vectors, α1-pCIneo, α1-pGFP (GFP, 
green fl uorescent protein), β3-pCMV, and α2δ1-
pCDNA3, representing the Cav1.4 calcium 
channel subunits, were kindly provided by 
Professor Jörg Striessnig (Hoda et al. 2005; 
Koschak et al. 2003). Mouse clarin-1 cDNA 
cloned in pEGFP-N1 expression vector 
(Clontech) served as a transfection and 
plasmamembrane localization control. For 
transient transfections, BHK-21, COS-1 or 
HEK-293 cells were plated on 15 mm coverslips 
in 6-well plates 20 hrs before transfection with 
FuGENE 6 (Roche, Indianapolis, IN, USA) 
or Lipofectamine (Invitrogen) transfection 
reagent. The human Cav1.4 α1 cDNA clone 
was transfected alone (1.5µg), or cotransfected 
together with the auxillary subunits, β3 and α2δ1, 
in equimolar concentrations. After transfec-
tions, cells were incubated either at 37˚C for 
12-72 hrs, at 30˚C for 12-48 hrs, or fi rst at 37˚C 
for 6 hrs and then at 30˚C for the next 12-48 
hrs.
2.9  Immunofl uorescence staining of   
 transfected cells (U)
The α1F proteins in transfected cells were 
visualized with a GFP-tag or indirect immuno-
fl uorescence. Cells growing on coverslips were 
fi xed with 4% paraformaldehyde in phosphate 
buffered saline (PBS), permealized with 
0.2% saponin and then blocked with 2-5% 
bovine serum albumin or 10% nonimmune 
donkey serum (Jackson ImmunoResearch, 
West Grove, PA, USA). Polyclonal antibody, 
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produced in sheep against the human Cav1.4 
α1F SNEKDLPQENEGLVPGVEK peptide, was 
kindly provided by Dr. Catherine Morgans 
(Morgans 2001). Secondary donkey anti-
sheep antibodies were either Cy2 (Jackson 
ImmunoReseach) or Alexa546 (Invitrogen) 
conjugated. Stained cells were viewed 
and documented with a Zeiss Axioplan 2 





1  Identifi cation of a third X-linked 
 cone-rod dystrophy locus,CORDX3 (I)
1.1 Linkage and haplotype analyses
In order to localize the disease gene for cone-
rod dystrophy (CORDX, formerly COD) in the 
Finnish family (Mäntyjärvi et al. 2001), we 
performed linkage and haplotype analyses 
with markers from Xp22.32 to Xq28, covering 
both of the previously identifi ed loci, CORDX1 
(formerly COD1) in Xp21.1-11.4 (Bergen et al. 
1993; Hong et al. 1994; Seymour et al. 1998) 
and CORDX2 (formerly COD2) in Xq27-28 
(Bergen and Pinckers 1997). At the initial 
stage of our mapping studies, the disease 
gene for CORDX1 was still unidentifi ed, and 
the critical regions for CORDX1 and CORDX 
of the Finnish family were partially overlapping 
for approximately 300 kb in the Xp11.4 region 
(Figure 4). After the causative gene, RPGR, 
for CORDX1 was identifi ed (Demirci et al. 
2002; Yang et al. 2002), recombination events 
between the disease gene of the Finnish family 
and markers in the CORDX1 region, including 
an RPGR intragenic SNP1, resulted in exclusion 
of the RPGR gene as the causative gene in 
the Finnish CORDX family. Sequencing of the 
RPGR gene verifi ed the exclusion. Lod scores 
for all the markers in the Xq27-28 region were 
negative, also excluding the CORDX2 region 
as the site of the disease gene in the Finnish 
CORDX family. We were thus able to identify a 
new CORDX locus, CORDX3 (I, MIM 300476).
Two-point linkage analysis showed linkage 
without recombination between CORDX3 and 
ten markers from the pericentromeric region of 
the X-chromosome (Figure 4). Lod scores were 
signifi cant for four of these markers, DXS993 
(Zmax=3.90 at θ=0.00), MAOB (Zmax=3.48 at 
θ=0.00), and DXS1055 (Zmax=3.18 at θ=0.00) 
from the Xp region, and DXS1194 (Zmax=4.10 
at θ=0.00) from the Xq region. DXS10042 in 
the Xp11.4 region and DXS8060 in Xq13.1 
were the closest fl anking markers showing 
recombinations with respect to the disease 
gene. The genetic distance between these 
markers was approximately 35 cM (Figure 
4). Genetic heterogeneity among cone-rod 
dystrophies (see Table 1), and among inherited 
retinal diseases in general, is a well-established 
phenomenon. Therefore, identifi cation of a new 
CORDX locus was not surprising, but further 
expanded the knowledge concerning the 
genetic background of cone-rod dystrophies.
 
1.2 Candidate gene screening from the
  CORDX3 region
A total of nine candidate genes were screened 
for mutations from the CORDX3 region (I, II) 
(Figure 4). From the 300 kb region that was 
initially shared by CORDX1 and CORDX3, 
four genes, DDX3, NYX, GPR34, and I-4 were 
screened, but no mutations were identifi ed (I). 
After identifying CORDX3 as a distinct locus, 
we continued candidate gene screening by 
choosing functionally attractive genes for 
mutation analysis from the CORDX3 region. 
Disease genes for other inherited retinal 
diseases, including NDP responsible for Norrie 
disease (Berger et al. 1992) and RP2 causing 
retinitis pigmentosa (Schwahn et al. 1998), 
were chosen because of the well-known 
allelic heterogeneity among inherited retinal 
diseases. TIMP1 was an attractive candidate 
gene because of its involvement in modifi cation 
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of the interphotoreceptor matrix (Plantner et al. 
1998). Also, mutations in TIMP3, which belongs 
to the same gene family as TIMP1, were known 
to cause Sorsby’s fundus dystrophy (Weber 
et al. 1994). ARR3, on the other hand, was 
screened because of its retina-specifi city 
and involvement in retinal signal transduction 
(Murakami et al. 1993). Screening of these four 
new candidate genes revealed no mutations 
(I). All the nucleotide changes observed were 
polymorphisms present also in subsets of the 
100 control samples studied. 
2 The calcium channel α1-subunit  
 gene, CACNA1F, as a candidate   
 gene in retinal diseases (II, III, U)
2.1 CACNA1F gene structure and function
The L-type calcium channel α1F-subunit gene, 
CACNA1F, is a functional candidate gene 
for many retinal diseases mapping to the 
same genetic interval as CACNA1F, including 
diseases studied in this thesis. The CACNA1F 






















Marker Location cM Lod score at θ=0
DXS8051 Xp22.32 12.03 -∞
DXS1053 Xp22.31 22.04 -∞
DXS1229 Xp22.13 32.98 -∞
DXS1048 Xp22.11 37.35 -∞
DXS1242 Xp21.2 - 0.31
DXS1110 Xp21.1 - -∞
rs3888228 Xp21.1 - 0.05
SNP1 Xp21.1 - -∞
DXS1068 Xp11.4 52.63 -∞
DXS8025 Xp11.4 52.63 -∞
DXS556 Xp11.4 - -∞
DXS8015 Xp11.4 53.71 -∞
DXS8042 Xp11.4 53.71 -∞
DXS10042 Xp11.4 - -∞
CA23 Xp11.4 - 1.78
CA20 Xp11.4 - 1.89
DXS993 Xp11.4 62.50 3.90
DXS8012 Xp11.4 62.50 0.92
DXS1201 Xp11.4 63.59 2.26
MAOB Xp11.3 - 3.48
DXS1055 Xp11.23 72.38 3.18
DXS1194 Xq11.2 83.30 4.10
DXS1275 Xq12 89.91 2.95
DXS559 Xq12 - 2.67
DXS8060 Xq13.1 93.17 -∞
DXS441 Xq13.1 - -∞
DXS1225 Xq13.2 93.17 -∞
DXS6801 Xq21.31 99.73 -∞
DXS8096 Xq22.1 110.72 -∞
DXS8059 Xq25 135.96 -∞
DXS8071 Xq26.2 144.78 -∞
DXS1227 Xq27.1 155.88 -∞
DXS8043 Xq27.3 167.87 -∞
DXS998 Xq27.3 173.40 -∞
DXS1215 Xq28 175.32 -∞
DXS1123 Xq28 - -∞
DXS8061 Xq28 181.08 -∞
DXS9897 Xq28 - -∞
DXS1073 Xq28 184.34 -∞
CORDX1
= RPGR
Figure 4. Two-point linkage between the disease gene of the Finnish CORDX family and X-
chromosomal markers, the locations of the X-linked cone-rod dystrophy loci (CORDX), and the 
candidate genes chosen for mutation analysis.
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the Xp11.23 region (Bech-Hansen et al. 1998; 
Strom et al. 1998). The gene was fi rst identifi ed 
as a causative gene for an incomplete type of 
congenital stationary night blindness, CSNB2 
(Bech-Hansen et al. 1998; Strom et al. 1998). 
Subsequent studies indicated mutations also 
in patients with related retinal phenotypes, 
including CSNB2 with atypical retinal atrophy 
and visual fi eld defects (Nakamura et al. 2002), 
retinal and optic disc atrophy with progressive 
decline of visual function (Nakamura et al. 
2003), severe CSNB2-like phenotype with 
intellectual disability and symptoms in female 
carriers (Hope et al. 2005), and AIED-like 
phenotype (Wutz et al. 2002).
The CACNA1F gene codes for the α1F-subunit 
of the L-type Cav1.4 calcium channel. In the 
rat and mouse retina, the channel is located 
in both the outer plexiform layer (OPL) and in 
lesser amounts in the inner plexiform layer (IPL) 
(Berntson et al. 2003; Morgans 2001; Morgans 
et al. 2001; Morgans et al. 2005). In the OPL, 
the channel is colocalized with rod and possibly 
cone photoreceptor synaptic ribbons, which 
are part of the active zone complex involved in 
glutamate release from photoreceptor synaptic 
terminals. In macaque retina, with more cones 
than rodent retina, the channel is clearly present 
in both the rod and the cone terminals (Wässle 
et al. 2003). The expression profi le of CACNA1F 
is retina-enriched, but CACNA1F mRNA and/
or α1F-protein is also present in adrenal gland, 
spleen, spinal cord, bone marrow, thymus, 
skeletal muscle (McRory et al. 2004), pineal 
gland (Hemara-Wahanui et al. 2005), and T-
cells (Kotturi et al. 2003), suggesting a wider 
role in human physiology. Many of the tissues 
expressing CACNA1F are associated with the 
immune system, however, potential defects of 
immune response in patients with CACNA1F 
mutations have not been reported. 
2.2 CACNA1F mutations in Finnish 
 patients
2.2.1 Mutation of CACNA1F leads 
 to CORDX3 (II) 
The CACNA1F gene was an attractive candidate 
gene for CORDX3, because of its involvement 
in retinal signaling and in the pathogenesis 
of several retinal diseases. Sequencing of 
the CACNA1F gene from CORDX3 patients 
revealed a novel deletion/insertion mutation, 
IVS28-1 GCGTC>TGG, in the splice acceptor 
site of intron 28 (II). This mutation co-
segregated with the disease phenotype in the 
CORDX3 family and was not observed in the 
200 control chromosomes studied.
As the identifi ed mutation affected a splice site 
of the CACNA1F gene, we decided to study the 
effect of this mutation on pre-mRNA splicing 
(see section 2.3). Naturally, we could not study 
CACNA1F pre-mRNA splicing in patients’ retina, 
which is the main site of CACNA1F expression. 
We therefore studied the expression of 
CACNA1F mRNA in normal controls in tissues 
that would also be easily obtainable from the 
patients, such as fi broblast and lymphoblastoid 
cells. RT-PCR experiments indicated that 
CACNA1F mRNA was expressed, although at 




2.2.2  Finding CACNA1F mutations in AIED (III)
The CACNA1F gene has long been a positional 
as well as a functional candidate gene also for 
AIED. Even though mutations were found from 
AIED-like patients, surprisingly, a previous 
sequencing study identifi ed no mutations in 
the genomic DNA of patients belonging to the 
original AIED family (Wutz et al. 2002). Because 
the CACNA1F gene expression was originally 
reported to be restricted to the retina (Bech-
Hansen et al. 1998; Strom et al. 1998), and 
retinal RNA from AIED patients for mutation 
studies was unavailable, mutations in intronic 
or regulatory regions could not be ruled out. 
Our studies of the CORDX3 family indicated 
CACNA1F expression also in lymphoblastoid 
cells (II), which were easily available from AIED 
patients, and thus enabled the screening the 
CACNA1F gene from both genomic DNA and 
mRNA. 
Our initial sequencing of the CACNA1F gene 
from genomic DNA of an AIED patient revealed 
no mutations either. We, however, failed to 
amplify exon 30 robustly with published primers, 
while other exons amplifi ed properly. To amplify 
and sequence exon 30, we then used new 
primers from the nearby exons. Amplifi cation 
of exons 27 to 31 revealed a novel 425 base 
pair (bp) genomic deletion, covering part of 
intron 29 (133bp), the whole exon 30 (111bp) 
and part of intron 30 (181bp) (III). Sequencing of 
CACNA1F mRNA from patient lymphoblastoid 
cells confi rmed the skipping of exon 30. The 
mutation was present in all affected males and 
female carriers of the AIED family, and it was 
absent from unaffected family members and 
the 121 control chromosomes studied. 
2.2.3  CACNA1F mutation in a Finnish   
     CSNB2 patient (U)
The CACNA1F gene was sequenced from 
a Finnish CSNB2 patient based on the 
observation that the patient showed clinical 
features of both CSNB2, and CORDX3. A novel 
mutation, IVS16+2T>C, in the splice donor site 
of intron 16 was identifi ed (U). The mutation 
was present in the patient and his carrier 
mother, but it was absent from the 100 control 
chromosomes studied.
2.3  Alternative splicing of the 
 CACNA1F gene
2.3.1 CACNA1F mutations affect 
 pre-mRNA splicing (II, III, U)
As the three newly-identifi ed mutations, 
IVS16+2T>C (U), IVS28-1 GCGTC>TGG (II), 
and 425 bp genomic deletion of exon 30 and 
adjacent intronic regions (III), affected splice 
sites of the CACNA1F gene, we carried out 
CACNA1F mRNA analysis from exon 14 to 18 
and from exons 27-28 to 33-34 fl anking the 
mutation sites. Analysis of CACNA1F mRNA 
from lymphoblastoid cells or activated T-cells 
of patients and controls revealed aberrant 
splicing products due to mutations as well 
as novel alternatively spliced wild-type (wt) 
CACNA1F variants (II, III, U, Figure 5A). 
The analysis of the CACNA1F exon 28-30 
region from the lymphoblastoid-derived 
RNA of CORDX3 patients with the IVS28-1 
GCGTC>TGG mutation revealed fi ve aberrantly 
spliced variants (II, Figure 5A, b-f). Control 
samples showed only wt transcript. The analysis 
of RNA further upstream of the mutation site 
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revealed two additional splice variants: skipping 
of exon 32 and skipping of exons 31-32 (Figure 
5A, i-j). These variants were present also in 
all control samples studied (II, III). Analysis 
of RNA of activated T-cells from a CORDX3 
patient and carrier female revealed only two 
of the aberrant splice variants (II, Figure 5A, d 
and f). Skipping of exon 32 was present in both 
patient and control T-cells, whereas skipping 
of exons 31-32 was undetectable in T-cells. All 
variants could not be sequenced from activated 
T-cells due to RT-PCR favoring major variants 
over low-expressed variants. There is thus a 
possibility that the CORDX3 mutation may lead 
to formation of yet additional aberrant splicing 
products with very low expression level. The 
fi ve aberrant splice variants observed predict 
different sized in-frame deletions from the III-IV 
linker region to repeat domain IV, or premature 
termination codons (PTC) in the linker between 
repeat domains III and IV of the Cav1.4 channel 
(Figure 5B, b-f). The variants with PTCs are 
most likely destroyed by nonsense-mediated 
mRNA decay (NMD), a pathway that degrades 
mRNAs that have PTCs in their open reading 
frames >50 nucleotides upstream of the last 
exon-exon junction to prevent accumulation of 
potentially toxic polypeptide fragments (Baker 
and Parker 2004). This suggestion is supported 
by a recent transient expression study, which 
indicated that PTC in the intracellular C-
terminus of Cav1.4 seems to lead to the absence 
of the protein (Hoda et al. 2005). Quantitative 
RT-PCR analysis, however, is needed to 
confi rm the actual levels of mRNA variants 
with PTCs and the probable involvement of 
NMD. Variants which predict in-frame deletions 
in repeat domain IV may produce a protein. 
Two of these variants remove IVS1 or IVS1-
S2 transmembrane segments, and the third 
predicts a small deletion of the III-IV linker 
region. Removal of the IVS1 transmembrane 
segment, furthermore, predicts altered 
membrane topology for the C-terminal part 
of the protein. Functional consequences of 
these deletions on the Cav1.4 channel are 
unknown, however, even missense mutations 
are known to cause marked changes in channel 
gating, or completely prevent the channel from 
functioning (Hoda et al. 2005; Peloquin et al. 
2007). Based on these observations it is highly 
likely that the mutation in CORDX3 patients 
results in reduced levels of the Cav1.4 channel 
with altered or absent channel function.
In AIED, which is caused by the 425 bp genomic 
deletion of CACNA1F exon 30 and fl anking 
intronic regions, analysis of lymphoblastoid RNA 
revealed an aberrant splicing product which 
lacked exon 30 (III, Figure 5A, g). The variants 
lacking exon 32 and exons 31-32, observed in 
CORDX3 patients and control samples, were 
also observed in the AIED patient. Deletion 
of exon 30 predicts in-frame deletion of the 
protein, involving transmembrane domain 
IVS2 and the preceding extracellular loop. As 
a consequence, membrane topology of the 
C-terminal part of the protein is predicted to 
change. A similar kind of membrane topology 
change is predicted by one of the aberrant 
CORDX3 splice variants (Figure 5B, d), as well 
as the alternative wt CACNA1F splice variant 
in lymphoblastoid cells with skipping of exons 
31-32 (Figure 5B, j). Because of the altered 
membrane topology, these variants are likely 
to yield nonfunctional channels or signifi cantly 
altered channel function (see section 2.3.2).
The analysis of the CACNA1F exon 14-18 
region from lymphoblastoid RNA of the CSNB2 
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< Figure 5A. CACNA1F transcripts detected with RT-PCR. Exon 28-31 region: normal splicing 
product (a), fi ve different outcomes of the mutation, IVS28-1 GCGTC>TGG, in CORDX3 
patients (b-f), and outcome of the 425bp deletion in AIED patients (g). Exon 30-33 region: normal 
splicing product (h), and two alternative splice variants (i-j). Exon 15-17 region: normal splicing 
product (k), four alternative splice variants (l-o), and outcome of the mutation, IVS16+2T>C, in a 
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B. Putative membrane topology of the human L-type calcium channel Cav1.4 α1F subunit encoded 
by CACNA1F, and the predicted consequences of detected mutations (in colors) and alternative 
splice variants (in black) for the protein. The alphabetical order of the variants is similar in 5A and B. 
Numbering is according to NCBI nucleotide (NM_005183) and protein (NP_005174) sequences. 
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patient with the mutation IVS16+2T>C revealed 
an aberrantly spliced variant which was absent 
from a control sample (U, Figure 5A, p). The 
control sample showed four alternative splice 
variants (Figure 5A, l-o) in addition to the wt 
transcript containing all exons. The mutation-
induced aberrant splice variant predicts an in-
frame deletion/insertion in the IIS6 segment and 
the membrane associated loop between IIS5-
S6 (Figure 5B, p). The functional consequence 
of this mutation is unknown, however, it is 
predicted to result in an nonfunctional channel 
or markedly altered channel function.  
2.3.2  Alternative splicing enhances   
 channel diversity (II, III, U)
Splicing, i.e. removal of introns from pre-mRNA, 
is an important step in gene expression. While 
the estimation of the number of genes in the 
human genome is getting smaller and smaller, 
the importance of alternative splicing as a 
mechanism increasing the functional diversity 
of proteins is becoming more apparent. In 
the early 1980’s, researchers estimated that 
5% of genes in higher eukaryotes undergo 
alternative splicing, but according to the latest 
reports at least 35-60% of the genes in the 
human genome show evidence of alternative 
splicing (Modrek and Lee 2002). Alternative 
splicing may affect the protein in a variety of 
ways, for example by replacing the N- or C-
terminus, adding or removing a functional 
unit, or producing a truncated protein product. 
Consequently, the binding properties, post-
translational modifi cations, intracellular 
localization, enzymatic activity, or the stability 
of the protein may change (Stamm et al. 
2005). Alternative splicing is often tissue- or 
development-specifi c, and therefore certain 
transcript variants may be present only in 
certain cell types or specifi c developmental 
stages. In addition to the traditional view 
that alternatively spliced transcripts encode 
alternative proteins, recent data suggests that 
many genes produce also other transcripts 
that may include sequences from both strands, 
neighboring genes, or intragenic regions 
(Birney et al. 2007; Gingeras 2007). Some of 
these transcripts, called transcripts of unknown 
function (TUFs), appear to have a role in the 
regulation of protein-coding gene expression, 
and others may have as yet unknown regulatory 
functions (Gingeras 2007).
For the CACNA1F gene, alternative splicing has 
been described for exons 1, 2, 9 (Boycott et al. 
2001), and 32 (McRory et al. 2004) in retina, and 
for exons 31, 32, 33, 34, and 37 in lymphocytes 
(Kotturi and Jefferies 2005). Our experiments 
with lymphoblastoid RNA indicated alternative 
splicing for CACNA1F exons 15, 16, 17, 31, 
and 32 (Figure 5A, i-j, l-o). Alternative splicing 
within exons 15, 16, and 17 involved the use of 
alternative splice acceptor sites (U), whereas 
exons 31 and 32 were alternative exons either 
included in the transcript or excluded by exon 
skipping (II, III). Analysis of a retinal cDNA library 
demonstrated the skipping of exon 32, while 
skipping of exons 31-32 did not occur (III). 
Exon 32 codes for a short sequence, 
NGGHLGE, located in the extracellular loop 
between segments IVS3-S4 of the Cav1.4 
channel. Wt splice variants involving skipping of 
a short exon constituting part of this loop have 
also been described for other L-type calcium 
channels, Cav1.1, Cav1.2, and Cav1.3 (Barry et 
al. 1995; Perez-Reyes et al. 1990; Safa et al. 
2001; Yu et al. 1992). The changes in this loop 
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between segments S3-S4 may infl uence the 
voltage dependence of the channels because 
of the close vicinity of the loop to the S4 
segment, which is known to act as a voltage 
sensor initiating conformational changes that 
open the channel (Bezanilla 2002). For example, 
Cav1.2 channels in heart and brain, which have 
a shorter IVS3-S4 linker region due to skipping 
of an exon, show altered voltage-dependent 
activation (Tang et al. 2004). This may infl uence 
the shape or duration of action potentials. Also, 
N-type Cav2.2 and P/Q-type Cav2.1 calcium 
channels with an insertion of two amino acids 
in the loop between segments IVS3-S4 due 
to alternative splicing show differences in 
activation kinetics and voltage-dependence of 
gating, as well as in sensitivity to spider peptide 
toxin ω-aga IVA (Bourinet et al. 1999; Lin et al. 
1999). 
The wt variant which involves skipping of 
exons 31-32 of the CACNA1F gene (Figure 
5A, j) was absent from retina, however, it may 
have a specifi c function in lymphoblastoid 
cells (II, III). This variant leads to deletion of 
the IVS3 transmembrane segment and part 
of the IVS3-S4 linker region, suggesting an 
altered membrane topology of the C-terminal 
part of the protein. Similar splice variants have 
been described also for the L-type calcium 
channel Cav1.3 in rat neuroendocrine GH3 
cells (Safa et al. 2001), and for Cav1.2 in human 
adult heart and fetal brain (Tang et al. 2004). 
Functional consequences of these variants are 
unknown. An alternative Cav1.4 splice variant 
in lymphocytes, which involves skipping of 
exons 31-34 and exon 37, leads to deletion of 
the IVS3-S5 region and thus probably alters 
the membrane topology (Kotturi and Jefferies 
2005). This variant is hypothesized to form a 
functional, but voltage-insensitive, channel. 
The variants which show skipping of exons 31-
32 may also cause changes in channel voltage-
sensitivity, or lead to as yet unknown channel 
function, or a nonfunctional channel. 
In the CACNA1F exon 14-18 region four 
alternatively spliced variants were present (U). 
These variants use alternative splice acceptor 
sites either in exon 15, intron 15, exon 16, or in 
intron 17. The variant, which uses an alternative 
splice acceptor in intron 17 (Figure 5, o), leads 
to an in-frame deletion/insertion in the IIS6 
segment and the following domain II-III linker 
region. This linker region mediates interactions 
with effector proteins, and variations in this 
region may lead to differences in channel 
function. For example, rat and rabbit splice 
isoforms of P/Q-type Cav2.1 channels with 
sequence differences in the domain II-III linker 
region have different patterns of interactions 
with synaptic proteins (Kim and Catterall 1997). 
The other three CACNA1F variants observed in 
the exon 14-18 region lead to PTCs in the IIS4-S5 
intracellular loop or in the IIS5-S6 extracellular 
loop (Figure 5, l-n). The production of transcripts 
with PTCs may serve as a mechanism for gene 
expression regulation (Stamm et al. 2005). 
Variants with PTCs are subjected to NMD 
for degradation, and thus the overall protein 
expression level is reduced. Approximately 18-
25% of all transcripts are down-regulated by 
NMD. In some cases, transcripts may, however, 
escape NMD (Bachmann et al. 2006), or 
transcripts likely to be subjected to NMD may 
produce small amounts of protein (Dreumont et 
al. 2005). If the CACNA1F variants with PTCs 
are translated, they produce truncated protein 
products with only repeat domains I-II present. 
Several two-domain variants generated by 
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alternative splicing exist in VDCCs. In rabbit 
heart alternative splicing removes exons 17-
18 or exon 19, leading to expression of an L-
type Cav1.2 channel consisting only of repeat 
domains I-II (Wielowieyski et al. 2001). The 
same channel in human fi broblasts predicts 
a two-domain isoform resulting from the use 
of an alternative splice acceptor in exon 15 
(Soldatov 1994). A similar two-domain protein 
variant of the P/Q-type Cav2.1 channel is 
present in synaptic membranes of rabbit brain 
(Scott et al. 1998). In vitro expression of N-type 
Cav2.2 two-domain variants provides clues 
to the signifi cance of such truncated channel 
forms (Raghib et al. 2001). When domains I-II 
or III-IV are expressed individually with auxillary 
subunits no functional channels are formed, 
however, when domains I-II or domains III-IV 
are coexpressed with full-length Cav2.2, they 
act in a dominant-negative manner suppressing 
expression of the full-length channel. Based on 
these data, it seems that the newly-observed 
Cav1.4 variants with PTCs lead to down-
regulation of the channel in lymphoblastoid 
cells, whether translated or not.
Alternative splicing seems to be an important 
means to produce functional diversity among 
VDCCs, or down-regulate the expression level 
of the channel. A number of splice variants 
have already been described for all VDCCs, 
however, the total degree of alternative splicing 
remains still unknown. Systematic scanning of 
loci for alternative splicing for CACNA1C (Tang 
et al. 2004), and CACNA1A (Soong et al. 2002), 
has revealed extensive alternative splicing, 
suggesting that splice-related functional 
diversity of VDCCs may be considerably 
larger than is currently known. Comprehensive 
transcript scanning will probably reveal as 
yet unidentifi ed splice variants also for the 
CACNA1F gene.
2.4  CACNA1F mutation spectrum and   
 associated phenotypes (II, III, U)
To date, a total of 57 CACNA1F mutations 
have been identifi ed (Table 3), including 
the mutations identifi ed in this thesis. The 
mutation spectrum is wide, including missense, 
nonsense, splice site, insertion, and deletion 
mutations. Mutations are distributed equally 
along the entire gene, and no mutation hot 
spots exist. Most CACNA1F mutations lead 
to a CSNB2 phenotype, however, mutations 
are present also in patients with divergent 
but overlapping diagnoses, including CSNB2 
with atypical retinal atrophy and visual fi eld 
defects (Nakamura et al. 2002), retinal and 
optic disc atrophy with progressive decline of 
visual function (Nakamura et al. 2003), severe 
CSNB2-like phenotype with female carrier 
symptoms and intellectual disability (Hope et al. 
2005), and an AIED-like phenotype (Wutz et al. 
2002). In this thesis, CACNA1F mutations were 
also found in cone-rod dystrophy (CORDX3) 
patients (II), patients of the original AIED family 
(III), as well as in a Finnish CSNB2 patient (U).
 
2.4.1  Studies of functional consequences of  
 CACNA1F mutations (U)
Over half of the known CACNA1F mutations 
are nonsense mutations, deletions, insertions, 
or splice site mutations predicting PTCs (Table 
3, mutation numbering according to the NP_
005174 protein sequence), and thus are likely 
to lead to loss-of channel function, which 
is suggested to be the disease mechanism 
underlying CSNB2. The functional studies 
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have supported this hypothesis. Functional 
expression of C-terminal Cav1.4 mutant, 
W1451X, reveals that a truncated mutant 
channel does not support ionic currents due 
to the lack of protein expression (Hoda et al. 
2005). 
The transient expression studies and patch 
clamp recordings of the Cav1.4 channel in HEK-
293 tsA-201 cells or Xenopus laevis oocytes 
bring light also to the disease mechanisms 
resulting from the CACNA1F missense 
mutations leading to CSNB2. Missense 
mutations S229P, G1018R, R1060W, and 
L1079P lead to the absence of channel 
function although the expression levels are 
indistinguishable from the wt channel (Hoda et 
al. 2005; Peloquin et al. 2007), indicating that 
change of only one amino acid may prevent 
the channel from functioning completely. On 
the other hand, missense mutations G369D 
and F753C do not prevent channel function 
but cause profound changes in Cav1.4 gating 
properties, suggesting gain-of-function as 
a disease mechanism in these cases (Hoda 
et al. 2005; Peloquin et al. 2007). Finally, the 
mutations R519Q and L1375H suggest nearly 
normal or unchanged channel properties, but 
reduce the expression level of the channel 
(Hoda et al. 2006). Mutants G674D and A928D 
also suggest unchanged channel properties 
(McRory et al. 2004), however, the expression 
levels of these mutants have not been studied, 
and it is possible that they function in a similar 
way as R519Q and L1375H by reducing the 
channel expression (Hoda et al. 2006). 
Previous expression studies suggest both 
loss-of-function and gain-of-function as a 
disease mechanism underlying the CSNB2 
phenotype. Results from the expression 
studies are not, however, totally in accord 
with each other. Hoda and coworkers (2005) 
reported that the W1451X mutant leads to the 
absence of protein expression. An independent 
study reported normal current amplitudes and 
gating kinetics for the same mutant (McRory 
et al. 2004). These observations may be 
due to Cav1.4 constructs, which represent 
different splice variants, and in addition have 
polymorphic amino acid changes in four 
positions. Additional studies must, however, 
clarify the role of different splice variants and 
polymorphisms in Cav1.4 channel function.
In this thesis we aimed to investigate the 
functional consequences of CACNA1F 
mutations leading to CORDX3 and AIED 
phenotypes by analyzing the subcellular 
localization of a mutant Cav1.4 channel in 
transiently transfected cells (U). We started 
the functional studies by expressing the wt 
Cav1.4 in BHK-21, HEK-293, and COS-1 cells. 
The expression of wt Cav1.4 α1F subunit alone 
resulted in non-plasmamembrane localization 
of the channel subunit (Figure 6B) presumably 
due to the absence of auxillary subunits α2δ and 
β, which are crucial in traffi cking the channel 
to the plasma membrane (Canti et al. 2005; 
Maltez et al. 2005). The coexpression of wt α1F 
with the auxillary subunits α2δ1 and β3 resulted 
unexpectedly also in non-plasma membrane 
localization (Figure 6C). We expressed 
channel subunits in different cell lines and at 
lower temperatures to achieve lower channel 
expression levels, which could promote the 
correct folding and traffi cking of the channel 
to the cell membrane. All our expression 
experiments, however, resulted in aggregation 
of the channel protein in the cell, while the 
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Exon/intron Mutation Type Predicted consequence 
on protein product
Reference
2 c.148C>T nonsense p.Arg50Stop Boycott et al. 2001
2 c.151del5bp deletion p.Arg51fsStop Wutz et al. 2002
2 c.220T>C missense p.Cys74Arg Wutz et al. 2002
2 c.244C>T nonsense p.Arg82Stop Boycott et al. 2001, 
Wutz et al. 2002
4 c.466-469del4bp/
ins34bp
deletion/insertion p.Ser156/del2aa_ins12aa Nakamura et al. 2001, 
Boycott et al. 2001, 
Nakamura et al. 2003
intron 4 IVS4-2A>G splice site ? Boycott et al. 2001
6 c.685T>C missense p.Ser229Pro Wutz et al. 2002
6 c.781G>A missense p.Gly261Arg Wutz et al. 2002
7 c.832G>T nonsense p.Glu278Stop Zito et al. 2003
7 c.904insG insertion p.Arg302fsStop Nakamura et al. 2001
7 c.952-954delCTT deletion p.Phe318del Boycott et al. 2001
8 c.1106G>A missense p.Gly369Asp Strom et al. 1998, 
Boycott et al. 2001, 
Wutz et al. 2002
9 c.1218delC deletion p.Asp406fsStop Bech-Hansen et al. 1998, 
Zito et al. 2003
10 c.1315C>T nonsense p.Gln439Stop Wutz et al. 2002
13 c.1556G>A missense p.Arg519Gln Strom et al. 1998
14 c.1873C>T nonsense p.Arg625Stop Boycott et al. 2001, 
Wutz et al. 2002
15 c.2022G>A missense p.Gly674Asp Nakamura et al. 2001, 
Boycott et al. 2001
15 c.2071C>T nonsense p.Arg691Stop Zeitz et al. 2005
intron 16 IVS16+2T>C splice site p.707-747del_ins6aa U
17 c.2258T>G missense p.Phe753Cys Wutz et al. 2002
17 c.2267T>C missense p.Ile756Thr Hope et al. 2005
intron 19 IVS19-1G>C splice site ? Wutz et al. 2002
21 c.2579T>C missense p.Leu860Pro Wutz et al. 2002
21 c.2683C>T nonsense p.Arg895Stop Bech-Hansen et al. 1998, 
Boycott et al. 2001, 
Zeitz et al. 2005
intron 21 IVS21+3G>A splice site ? Wutz et al. 2002
intron 21 IVS21-2delCA splice site ? Wutz et al. 2002
intron 22 IVS22+1G>C splice site ? Nakamura et al. 2001
23 c.2783C>A missense p.Ala928Asp Boycott et al. 2001
24 c.2905C>T nonsense p.Arg969Stop Strom et al. 1998, 
Wutz et al. 2002, 
Zito et al. 2003
24 c.2932C>T nonsense p.Arg978Stop Nakamura et al. 2001, 
Nakamura et al. 2002
intron 24 IVS24+1G>A splice site ? Boycott et al. 2001
Table 3. Mutations of the CACNA1F gene associated with CSNB2 and related retinal diseases
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Mutation numbering is according to NCBI nucleotide (NM_005183) and protein (NP_005174) 
sequences. Del, deletion; ins, insertion; fs, frameshift; aa, amino acid.
25 c.3006-3008delCAT deletion p.Ile1003del Boycott et al. 2001
25 c.3052G>A missense p.Gly1018Arg Wutz et al. 2002
27 c.3125delG deletion p.Gly1042del Boycott et al. 2001
27 c.3166-3167insC insertion p.Leu1056fsStop Bech-Hansen et al. 1998, 
Strom et al. 1998, 
Boycott et al. 2001, 
Wutz et al. 2002
27 c.3178C>T missense p.Arg1060Try Strom et al. 1998, 
Wutz et al. 2002
27 c.3236T>C missense p.Leu1079Pro Wutz et al. 2002
intron28/
exon29






30 c.3631-3741del111bp deletion p.1211-1247del III
30 c.3673delC deletion p.Leu1225fsStop Bech-Hansen et al. 1998, 
Boycott et al. 2001
30 c.3691-3702del12bp deletion p.1231-1234del Strom et al. 1998, 
Wutz et al. 2002
31 c.3794G>T missense p.Ser1265Ile Zeitz et al. 2005
33 c.3886C>A missense p.Arg1296Ser Zeitz et al. 2005
33 c.3895C>T nonsense p.Arg1299Stop Bech-Hansen et al. 1998, 
Boycott et al. 2001, 
Wutz et al. 2002
intron 33 IVS33+2T>C splice site ? Wutz et al. 2002
35 c.4075C>T nonsense p.Gln1359Stop Strom et al. 1998, 
Wutz et al. 2002
35 c.4124T>A missense p.Leu1375His Strom et al. 1998, 
Wutz et al. 2002
intron 35 IVS35-1G>C splice site ? Wutz et al. 2002
37 c.4353G>A nonsense p.Try1451Stop Bech-Hansen et al. 1998, 
Boycott et al. 2001
38 c.4495T>C missense p.Cys1499Arg Wutz et al. 2002
38 c.4499C>G missense p.Pro1500Arg Wutz et al. 2002
39 c.4523T>C missense p.Leu1508Pro Wutz et al. 2002
39 c.4581delC deletion p.Leu1527fsStop Jacobi et al. 2003
intron 40 IVS40-2A>G splice site ? Boycott et al. 2001
41 c.4804A>T nonsense p.Lys1602Stop Strom et al. 1998, 
Wutz et al. 2002
46 c.5479C>T nonsense p.Arg1827Stop Wutz et al. 2002
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transfection control was transported properly to 
the plasma membrane (Figure 6A). McRory and 
coworkers (2004) and Peloquin and coworkers 
(2007) have reported that the wild type α1F 
subunit as well as two missense mutants 
expressed together with the auxillary subunits 
are targeted properly to the plasma membrane 
in HEK-293 cells. In their immunofl uorescence 
stainings the cells, however, appear spherical, 
while the morphology of the HEK-293 cell 
growing on cover slips is known to be irregular. 
It may be possible that overexpression of 
calcium channels in the plasma membrane 
of HEK-293 cells leads to osmotic swelling of 
the cells, and therefore the morphology of the 
cells is altered from irregular to spherical. This 
hypothesis seems, however, unlikely. We also 
saw spherical cells in our immunofl uorescence 
stainings (Figure 6D), but independent of the 
presence or absence of the auxillary subunits, 
and among untransfected control cells. Also, 
in our experiments the spherical cells were 
observed only occasionally, while most of the 
cells expressing the α1F–subunit were irregularly 
shaped and displayed protein aggregates. 
Therefore, the spherical cells most likely do 
not represent cells that express channels in 
their plasma membrane, but may represent 
apoptotic, necrotic, or unattached cells.  
Taken together, our results suggest that in 
transiently transfected cells, most of the wt 
Cav1.4 channel is misfolded and forms protein 
aggregates. Aggregate formation probably 
results from lack of the cell’s capacity to correctly 
fold and translocate the α1F-subunit to the 
plasma membrane due to its overexpression. If 
membrane proteins are improperly folded and 
translocated to the membrane, the hydrophobic 
side chains, which are normally embedded in 
the lipid bilayer, are exposed to the aqueous 
environment of the cytosol leading to non-
native conformations that can interact to form 
aggregates (Johnston et al. 1998). Normally, the 
proteasome degradation pathway destroys the 
unfolded proteins, however, when the capacity 
of this pathway is exceeded by an increase in 
protein expression, protein aggregates form. In 
our experiments, the expression of the Cav1.4 
channel protein even at lower temperatures 
did not yield low enough expression levels 
for channels to fold correctly, and proteins 
Figure 6. Subcellular localizations of wt mouse clarin-1 and wt human Cav1.4 calcium channel in 
transiently transfected HEK-293 cells visualized by GFP (A) or indirect immunofl uorescence with 
α1F-antibody (B-D). Mouse wt clarin-1 was targeted to the plasma membrane (A), whereas cells 
transfected with human wt calcium channel α1F-subunit (B) or with human wt calcium channel α1F-, 
α2δ1-, and β3-subunits (C) formed protein aggregates in the cell. Occasionally, the morphology of 
the cells appeared spherical (D).
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aggregated. Because the wt channel formed 
protein aggregates, and was not targeted 
properly to the plasma membrane, the effects 
of CORDX3 and AIED mutations on the 
channel targeting could not be assessed by 
this method. In previous studies, however, 
VDCCs have been overexpressed in HEK-293 
cells and their function has been measured 
by patch clamp recordings. It is possible that 
while most of the overexpressed channels 
misfold and form aggregates, some channels 
may still be transported to cell membranes and 
the function of those channels can be studied 
by patch clamp recordings. 
2.4.2  Comparison of CACNA1F-associated  
 phenotypes (II, III)
All the phenotypes associated with CACNA1F 
mutations show similarities to CSNB2, the 
disorder in which CACNA1F mutations were 
originally identifi ed, but some distinctive 
features also exist. The phenotypes of CORDX3 
and CSNB2 overlap to some extent, including 
the range of visual acuities, myopic refraction, 
and the ERG abnormalities. The onset of 
CORDX3, however, varies from childhood to 
adulthood, and the disease is progressive with 
respect to changes in visual acuity, refraction, 
color vision and visual fi eld (Mäntyjärvi et al. 
2001) whereas CSNB2 is considered to be 
stationary and observed early in life (Allen 
et al. 2003; Boycott et al. 2000; Jacobi et al. 
2003; Langrova et al. 2002; Nakamura et al. 
2001; Pearce et al. 1990; Tremblay et al. 1995). 
Congenital nystagmus, hyperopic refraction, 
and astigmatism >1.5 D are absent from 
CORDX3 patients, but are relatively common 
in CSNB2. Also, ocular fundus changes, other 
than myopic changes or irregular pigmentation 
in the macular area, are absent from CORDX3 
patients, while CSNB2 patients may show 
hypopigmented fundi, and pale discs. In dark 
adaptation, CORDX3 patients have an elevated 
or missing cone threshold and a normal or 
only slightly elevated rod threshold, whereas 
in CSNB2 the cone threshold is elevated but 
not missing, and the rod threshold is variably 
elevated, from 1 to 3 log units. 
CORDX3 has also many clinical features 
similar to other X-linked cone-rod dystrophies, 
CORDX1 (Brown et al. 2000; Hong et al. 1994; 
Jacobson et al. 1989) and CORDX2 (Bergen 
and Pinckers 1997; Pinckers and Timmerman 
1981), including the age of onset, slightly 
progressive nature of the disease, the range of 
visual acuities, myopic refraction, ERG fi ndings, 
and defects in visual fi elds. In CORDX1 and 
CORDX2, however, the fundus changes range 
from granular macula to bull’s eye maculopathy 
and geographical atrophy of the RPE, whereas 
CORDX3 patients show only myopic changes 
or irregular pigmentation in the macular area. 
Also, patients with CORDX3 lack hyperopia 
and astigmatism >1.5 D, which are present in 
some patients with CORDX1 and CORDX2.
The phenotype of AIED patients and AIED-
like patients is very similar to CSNB2. Re-
evaluation of the clinical features of the 
patients with AIED-like disease suggests that 
AIED-like disease and CSNB2 are identical 
disorders (Wutz et al. 2002). The presence of 
the CACNA1F mutation in our AIED patients (III) 
indicated that also AIED and CSNB2 are allelic 
diseases. Furthermore, the clinical features of 
these diseases seem to be nearly identical. 
There are only a few differences between the 
symptoms of the patients of the original AIED 
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family and patients with CSNB2. AIED has 
progressive myopic refraction, foveal dysplasia 
with no foveal refl ex, and a protan defect in 
color vision (Forsius and Eriksson 1964), 
whereas CSNB2 is apparently stationary with 
a normal fovea and mostly normal color vision, 
with tritan or mixed defects in some cases 
(Allen et al. 2003; Jacobi et al. 2003; Pearce et 
al. 1990). These differences are not, however, 
very notable, considering the high clinical 
variation both between and within CSNB2 
families. In most CSNB2 patients, even those 
with same mutation, one or more of the main 
clinical features (night blindness, myopia, and 
nystagmus) is absent (Boycott et al. 2000). The 
most prominent feature, which is present in all 
patients, is impaired visual acuity.
The unique CSNB2-like disease described in 
a Maori family with a novel CACNA1F mutation 
has similarities to CSNB2, but is considered a 
distinct clinical entity (Hope et al. 2005). The 
patients have a more severe phenotype with 
color vision abnormalities. Also, intellectual 
disability, autism, and epilepsy are present 
in several male patients. Moreover, carrier 
females in this family have ERG abnormalities, 
congenital nystagmus, glare, mild nyctalopia, 
and decreased visual acuity often associated 
with high myopia. Female carrier symptoms 
in CSNB2 are rare: only homozygous 
females show clinical manifestations similar 
to hemizygous males (Boycott et al. 2000). 
The unique phenotype in the Maori family is 
suggested to result from gain-of-function due 
to an I756T mutation in the CACNA1F gene 
(Hemara-Wahanui et al. 2005). Some gain-
of-function mutations, however, can lead to 
typical CSNB2 phenotypes (Hoda et al. 2005; 
Peloquin et al. 2007). Several male patients 
of the Maori family also show abnormal 
intelligence, autism, and epilepsy (Hope et al. 
2005). CACNA1F expression is not found in 
brain, but expression in pineal gland (Hemara-
Wahanui et al. 2005) suggests that possible 
defects in melatonin production may contribute 
to the phenotype seen in these patients 
(Musshoff and Speckmann 2003; Tordjman 
et al. 2005). Other patients with CACNA1F 
mutations do not, however, show features of 
neurological defects.
Patients with a CACNA1F mutation which leads 
to retinal and optic disk atrophy (Nakamura et 
al. 2003) share several features with CSNB2 
patients. The disease is, however, more severe 
with distinctive features of retinal atrophy with 
attenuated vessels, marked optic disc atrophy, 
and progressive decline of visual function 
resulting in poor visual acuity, while CSNB2 
is stationary and patients have essentially 
normal fundi with only myopic changes and 
pale discs. Atypical retinal atrophy is also 
present in another CSNB2 patient with a 
distinct mutation in CACNA1F (Nakamura et al. 
2002). Interestingly, the same CACNA1F gene 
mutations that are responsible for retinal and 
optic disc atrophy, and CSNB2 with atypical 
retinal atrophy, are both present also in patients 
with the typical CSNB2 phenotype (Boycott et 
al. 2001; Nakamura et al. 2001).
The variability in retinal diseases associated 
with CACNA1F mutations is evident, although 
all these phenotypes show some similarities 
to each other. Clear-cut phenotype-genotype 
correlation is, however, absent, which is 
also supported by the functional expression 
studies of the CACNA1F mutations. The 
reason for allelic heterogeneity is unclear. 
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The differences in phenotypes may, however, 
be caused by differences in the genetic 
backgrounds of patients, including the effect 
of possible modifi er genes. This idea is 
supported by studies of two Cacna1f mutant 
mouse strains, which show some differences 
in their phenotypes even though both carry a 
loss-of-function mutation in the Cacna1f gene 
(Chang et al. 2006; Mansergh et al. 2005). 
Both of these mouse strains show absence of 
Cav1.4 expression, and disorganized OPL with 
abnormal dendritic sprouting of second-order 
neurons, indicating that the Cav1.4 channel 
is vital for normal synapse formation and/or 
maintenance. Other retinal layers appear normal 
although Cav1.4 in wt mice is expressed also in 
IPL. The function of Cav1.4 in IPL is unclear and 
may be compensated for with Cav1.3, another 
calcium channel expressed in retina (Xiao 
et al. 2007). The functional characterization 
of the retina indicates differences between 
the two Cacna1f mutant mouse strains. In 
naturally occurring Cacna1f null-mutant mice, 
nob2 (no b-wave 2), scotopic ERG shows 
diminished b-waves and the presence of 
oscillatory potentials (Chang et al. 2006), while 
in Cacna1f-knockout mice both the b-wave and 
oscillatory potentials are absent (Mansergh et 
al. 2005). In photopic conditions, the nob2 mice 
show reduced amplitudes (Chang et al. 2006), 
whereas in Cacna1f knockout mice the cone 
ERG is undetectable (Mansergh et al. 2005). 
Based on the ERG fi ndings, the phenotype of 
nob2 mice resembles the phenotype seen in 
CSNB2 patients, whereas the phenotype of 
Cacna1f knockout mice is more severe with 
possible cone photoreceptor dysfunction, 
and thus more resembles the progressive 
retinal disorders due to CACNA1F mutations 
in humans. These phenotypic differences 
observed in the Cacna1f mutant mice, and the 
fact that in humans the clinical variability of 
patients does not correlate with the CACNA1F 
genotype or with the functional consequences 
of mutant channels, indicate the involvement of 
other genetic and possibly also environmental 
and stochastic factors in the phenotypic 




Inherited retinal diseases include various 
different disease types that lead to partial 
vision loss or even complete blindness. These 
diseases affect millions of people worldwide, 
and are the leading cause of blindness among 
the working population in developed countries. 
The genetic background of a growing number 
of inherited retinal diseases has been identifi ed 
with the development of molecular genetic 
techniques. As the number of known genes 
underlying inherited retinal diseases has 
grown, the presence of a vast degree of genetic 
and allelic heterogeneity has become more 
apparent. Genetic and allelic heterogeneity 
was observed also in this thesis, as we studied 
the genetic background of X-linked progressive 
cone-rod dystrophy (CORDX), and Åland Island 
eye disease (AIED). With linkage analysis in a 
large Finnish family, we could identify a third 
CORDX locus, CORDX3. Mutation analyses 
indicated that both CORDX3 and AIED result 
from mutations in the L-type calcium channel 
gene, CACNA1F. In most cases mutations 
of CACNA1F lead to another retinal disease, 
CSNB2, but mutations may also cause other, 
more severe retinal phenotypes with similarities 
to CSNB2. 
Genetic and allelic heterogeneity together 
with exceptional clinical heterogeneity make 
the diagnosis of inherited retinal diseases 
diffi cult. For example, cone-rod dystrophy 
may result from mutations in several distinct 
genes, including CACNA1F. Different muta-
tions of CACNA1F, on the other hand, can lead 
to several phenotypes having few or more 
symptoms in common. Furthermore, the phe-
notypic variability can be wide even among 
family members with the same CACNA1F 
mutation. Thus, a thorough clinical examination 
may be insuffi cient, and genetic tests may help 
to reach a correct diagnosis. In many cases, 
clinical examinations and family history are 
suffi cient for succesful genetic counseling of 
the families, including assessing the possible 
progression of the disease or the risk of 
transmitting the disease to children. Genetic 
studies, however, are important in carrier 
diagnosis and in confi rming the diagnosis 
in patients with mild or otherwise unclear 
phenotypes. Genetic tests are particularly 
important in sporadic cases, in which the mode 
of inheritance can not be deduced without 
knowledge of the genetic defect underlying 
the disease. In the future, the knowledge of the 
genetic defect may be used in the identifi cation 
of proper therapies for the patients. In the 
case of the CACNA1F gene routine genetic 
testing is challenging, because of the large size 
of the gene and lack of founder mutations or 
mutation hot spots. A commercial chip-based 
genetic test (Asper Ophthalmics) recently 
became available for the known CACNA1F 
gene mutations. In the case of novel mutations, 
however, genetic testing of patients requires 
sequencing of the whole gene, which is not 
commercially available at the moment. 
No effective therapy for inherited retinal 
diseases exists. The molecular genetic studies, 
functional protein experiments, and animal 
models, however, advance the understanding 
of cellular mechanisms in health and disease, 
and allow insights that may eventually lead to 
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